Early life stress regulates expression of risk genes for major depressive disorder by Zimmermann, Christoph Andreas
EARLY LIFE STRESS REGULATES EXPRESSION OF 
RISK GENES FOR MAJOR DEPRESSIVE DISORDER 
 
DISSERTATION DER FAKULTÄT FÜR BIOLOGIE DER LUDWIG-MAXIMILIANS-
UNIVERSITÄT MÜNCHEN 
 
 
Prepared at 
MAX PLANK INSTITUTE OF PSYCHIATRY 
DEPARTMENT OF TRANSLATIONAL RESEARCH IN PSYCHIATRY 
 
 
Christoph Andreas Zimmerman 
 
 
München 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Erstgutachter: PD Dr. Carsten Wotjak 
Zweitgutachter: Prof. Dr. Wolfgang Enard 
Tag der Abgabe: 24.08.2016 
Tag der mündlichen Prüfung: 28.04.2017
 
 
 
 
 
 
 
 
 
 
 
"Imagination is more important than knowledge. 
For knowledge is limited.” 
Albert Einstein 
 
 
 
 
 
 
 
 
 
 
 
Für meine Eltern 
 
 
Abstract 
Early life stress (ELS) is an important risk factor for the development of various mental disorders later 
in life. The hypothalamic-pituitary-adrenal (HPA) axis is the major physiological stress system and ELS 
during sensitive windows of development can induce long-lasting changes in its activity. Here, the long-
term regulation of the HPA axis was investigated by two approaches. First, the expression and 
promoter methylation of corticotropin releasing hormone (CRH), the main stress hormone of the HPA 
axis, was analyzed in a maternal separation mouse model of early life stress. CRH expression was 
estrous cycle dependent in female controls, but not in females with a history of early life stress. As 
underlying mechanism, CRH promoter methylation was investigated but no significant changes were 
found. Second, a group of genes identified in a human study was evaluated in a translational approach 
in ELS mice. Since glucocorticoid receptors (GR) play an important role in the negative-feedback control 
of the HPA axis, genetic variation in GR-dependent gene networks is hypothesized to modulate the 
long-term effects of ELS. Recent work discovered a subgroup of GR-response expression quantitative 
trait loci (eQTLs) in humans, which mapped to chromosomal regions identified in previous GWAS 
studies for major depressive disorder (MDD) as well as schizophrenia (SCZ). These eQTL genes were 
tightly connected in a literature-based co-expression network. To investigate the long-term regulation 
of this network in response to ELS, we used two experimental models, namely postnatal maternal 
separation and limited nesting material. In adult mice (3 month), the interaction of ELS with either an 
acute pharmacological treatment (corticosterone injection) or a sustained social stressor (chronic 
social defeat) were analyzed. Network analysis revealed specific co-expression networks in brain 
regions associated with the stress response, whereby the PVN and CA1 regions formed the most 
connections. A central gene in two of the networks was Pds5a, a cohesin regulatory factor, which is 
involved in the modulation of long-range enhancer interactions established by CTCF. Taken together, 
our results suggest brain region specific regulation of the identified eQTL genes in two independent 
mouse models of ELS, which strengthens a possible role for the development of psychiatric disorders 
in men. 
 
 
 
Zusammenfassung 
Frühkindlicher Stress (FS) ist ein wichtiger Risikofaktor für die Entwicklung psychiatrischer 
Erkrankungen (u.a. Depression, Schizophrenie und Angsterkrankungen) im Jugendlichen - und 
Erwachsenenalter. Die Hypothalamus-Hypophysen-Nebennieren (HPA)-Achse ist das zentrale 
physiologische Stress-System in Säugern und FS in kritischen Entwicklungsphasen kann nachhaltige 
Veränderungen der HPA-Achsen Aktivität auslösen. In dieser Arbeit wurden langfristige Anpassungen 
in der Regulation der HPA-Achse in Folge von FS in zwei Tiermodellen untersucht. Im ersten Abschnitt 
wurden die Expression und die Promotor-Methylierung von Corticotropin-Releasing-Hormon (CRH), 
welches eine herausragende Rolle in der Regulation der HPA-Achse einnimmt, in einem Mausmodell 
für FS analysiert. Die CRH-Expression hing in weiblichen Kontrollmäusen, aber nicht in Weibchen mit 
FS, vom Geschlechtszyklus ab. Als möglicher Mechanismus wurden Veränderungen in der CpG 
Methylierung des proximalen Promoterabschnittes des CRH Genes untersucht. Hierzu wurden in 
verschieden, voneinander unabhängigen experimentellen Kohorten keine Hinweise gefunden.  Im 
zweiten Abschnitt der Arbeit wurde in einem translationalen Ansatz ein humanes, Glukokortikoid-
Rezeptor (GR) abhängiges eQTL (engl. expression quantitative loci) Netzwerk in FS Mäusen untersucht. 
Der GR spielt eine wichtige Rolle in der negativen Rückkopplung der HPA-Achse und genetische 
Variationen in GR-abhängigen Gen-Netzwerken könnten daher die langfristigen Auswirkungen von FS 
beeinflussen. Besonderes Interesse fand hierbei eine Untergruppe von GR-eQTLs, die in 
chromosomalen Bereichen lokalisierten, die in genomweiten Assoziationsstudien (GWAS) für 
Depression (MDD) und Schizophrenie (SCZ) identifiziert wurden. Diese MDD/SCZ-assoziierten eQTL 
Gene formten in einer Literatur-basierten Analyse ein enges Co-Expressions-Netzwerk. Um die 
langfristige Regulation dieses Netzwerks durch FS zu untersuchen, wurden zwei experimentelle 
Stressmodelle verwendet. Postnatale Trennung der Neugeborenen vom Muttertier oder mütterlicher 
Stress infolge von unzureichendem Nestmaterial. In erwachsenen Mäusen wurde die Interaktion von 
FS mit der akuten Gabe eines GR-Antagonisten oder chronischem sozialen Stress getestet. Netzwerk-
Analysen zeigten, dass spezifische Co-Expressions-Netzwerke in ausgewählten Gehirnregionen mit der 
Stressantwort verknüpft sind, wobei im PVN und der hippocampalen CA1 Region die höchste 
Verknüpfungsdichte erreicht wurde. Ein zentrales Gen in zwei der Netzwerke war Pds5a, ein Cohesin-
regulierender Faktor, der die Chromatin-organisierende Funktion von CTCF und dessen Interaktion mit 
distalen regulatorischen Elementen beeinflusst. Zusammenfassend zeigen diese Ergebnisse eine 
Hirnregion-spezifische Regulation der identifizierten eQTL Gene in zwei unabhängigen Mausmodellen 
für FS, welcher somit eine Rolle in der Entwicklung von psychiatrischen Erkrankungen zukommen 
könnte.  
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1 Introduction 
1.1 Psychiatric disorders 
Psychiatric disorders are on the rise worldwide. According to the Global Burden of Disease Study 2010 
the highest number of years lived with disability worldwide can be attributed to mental and substance 
use disorders. Worryingly, the amount of disability-adjusted life years (DALYs) increased by over one 
third between 1990 and 2010 for mental and substance use disorders due to population growth and 
aging. Depressive disorders were hereby accounting for 40.5% of DALYs (Whiteford et al. 2013). Table 
1 summarizes the features, prevalence and heritability of the nine most common psychiatric and 
substance use disorders.  
Table 1: Defining features of nine psychiatric and substance use disorders (adapted from Sullivan et al. 2012) 
Name Life 
prevalence 
Heritability Essential characteristics Notable feature 
Alzheimer's 
disease 
0.132 0.58 Dementia, defining 
neuropathology 
Of the top ten causes of death 
in the United States, 
Alzheimer's disease alone has 
increasing mortality 
Attention-deficit 
hyperactivity 
disorder  
0.053 0.75 Persistent inattention, 
hyperactivity, impulsivity 
Costs estimated at ~US$100 × 
109 per year 
Alcohol 
dependence  
0.178 0.57 Persistent ethanol use 
despite tolerance, 
withdrawal, dysfunction 
Most expensive psychiatric 
disorder (total costs exceed 
US$225 × 109 per year) 
Anorexia nervosa 0.006 0.56 Dangerously low weight 
from self-starvation 
Notably high standardized 
mortality ratio 
Autism spectrum 
disorder  
0.001 0.80 Markedly abnormal social 
interaction and 
communication 
beginning before age 3 
Huge range of function, from 
people requiring complete 
daily care to exceptional 
occupational achievement 
Bipolar disorder  0.007 0.75 Manic-depressive i l lness, 
episodes of mania, 
usually with major 
depressive disorder 
As a group, nearly as disabling 
as schizophrenia 
Major depressive 
disorder  
0.130 0.37 Unipolar depression, 
marked and persistent 
dysphoria with physical 
and cognitive symptoms 
Ranks number one in the 
burden of disease in the world 
Nicotine 
dependence  
0.240 0.67 Persistent nicotine use 
with physical 
dependence (usually 
cigarettes) 
Major preventable risk factor 
for many diseases 
Schizophrenia  0.004 0.81 Long-standing delusions 
and hallucinations 
Life expectancy decreased by 
12–15 years 
Despite major efforts to understand the molecular nature of psychiatric disorders, only minor advances 
have been made. The most widely used antidepressant treatments are still selective serotonin 
reuptake inhibitors (SSRIs) like Citalopram, Fluoxetine or Paroxetine. Nevertheless, their exact 
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mechanism of action is still unclear. Therefore, psychiatric conditions are still referred to as ̀ disorders´ 
in contrast to `diseases´, where the pathophysiological mechanisms are well established (Sullivan et al. 
2012). 
The most common psychiatric disorder with a lifetime prevalence ranging from 8% to 16% worldwide 
is major depressive disorder (MDD) (Kessler et al. 2003; The WHO World Mental Health Survey 
Consortium 2004). MDD is characterized by severely depressed mood which lasts for at least two 
weeks (American Psychiatric Association and American Psychiatric Association 2000)  and is commonly 
accompanied by the loss of interest in normally enjoyable activities as well as a low self-esteem. Major 
depressive disorder shows comorbidity with various diseases with more than 50% of patients suffering 
from a comorbid anxiety or other psychiatric disorder. The presence of a comorbid disease results in 
increased severity and worse treatment outcome (Hirschfeld 2001).  
One psychiatric disorder that frequently manifests with comorbid depressive symptoms is 
schizophrenia (SCZ). Häfner et al. report a lifetime prevalence of depressive mood in 83% of first 
admission schizophrenia cases. As discussed later, there is also a substantial genetic risk overlap 
between major depression and SCZ. In this line of thought, they propose that depressive symptoms 
preceding schizophrenia are an early, mild manifestation of the same malfunctioning neurobiological 
processes (Häfner et al. 2005). 
1.2 Early life stress as risk factor for psychiatric disorders 
It is well recognized that adverse early life events result in an increased risk for the later development 
of psychiatric disorders (Heim and Nemeroff 2001, 2002; Lupien et al. 2009; Green J et al. 2010) . 
Numerous epidemiological studies have investigated the prevalence of child maltreatment and its 
influence on the development of psychiatric disorders. 
1.2.1 Prevalence of early life adversities 
Child maltreatment is a global societal challenge with a prevalence of 9.2 per 1000 children in the US 
population in 2012 (U.S. Department of Health and Human Services et al. 2013). Nearly four fifth of all 
maltreatment cases correspond to neglect followed by physical and sexual abuse (Figure 1). Even 
though the overall rate of maltreatment declined slightly (by 3.3 % over 5 years), the proportion of 
different types of maltreatment remained unchanged. 
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Figure 1: Types of child maltreatment. Percentage of maltreatment types for children in the US population 
(U.S. Department of Health and Human Services, et al. 2011). 
Surveys conducted in the US population revealed that 14.2% of men and 32.3% of women experienced 
sexual abuse as well as 22.2% of men and 19.5% of women experienced physical abuse during 
childhood (Briere and Elliott 2003). Another study found similar numbers with sexual abuse being 
reported by 4.3% and 12.4% of men and women respectively as well as 29.9% of men and 21.2% of 
women reporting physical abuse (MacMillan et al. 2001). The latest National Survey of Children’s 
Exposure to Violence also reports sexual assault in the past year in 3.7% of men and 4.6% of women 
between 14-17 years old (Finkelhor et al. 2015). The slight discrepancies between the numbers result 
from different definitions of the abuse types, the interview procedure, and the investigated time 
period among other variables. Generally, these retrospective interviews have several limitations. The 
response rate is typically rather low and thus a bias is expected. It can be argued that families which 
refuse participation are more likely to suffer from adverse social conditions and thus higher rates of 
abuse. Additionally, children may not be able to recall all of the adverse situations or caregivers may 
understate their children’s exposures. On the other hand, interviews may be suggestive and situations 
recalled as more aversive than actually experienced. In conclusion, children are exposed to a 
substantial amount of maltreatment during their childhood, but this can only be assessed incompletely 
by psychological studies.  
1.2.2 Relationship between early life adversities and psychiatric disorders 
A strong relationship between all kinds of early life adversities and mental di sorders has been 
established by numerous epidemiological and clinical studies. A dose -response relation between 
physical and sexual abuse as well as the witnessing of maternal battering in earl y life and adult mental 
health has been reported (Edwards et al. 2003). The Adverse Childhood Experiences study assessed 
childhood exposures like psychological, physical, and sexual abuse as well as several measures of 
household dysfunction. They found a graded relationship between the number of categories of 
adverse experiences and general health (summarized in Figure 2). For mental disorders, the risk 
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increased at least 4-fold when experiencing four or more categories of adverse childhood experiences  
(Felitti et al. 1998). 
 
Figure 2: Long-term effect of adverse childhood experiences on physical and mental health. 
Adverse childhood experiences often results in a vicious circle of health-risk behaviors. Low self-esteem abets smoking, 
a lcohol or drug abuse. Anxiety, anger and depressed mood are risk factors for obesity and sleep disturbances. The 
relationship between these behaviors and the development of organic diseases are often overseen. Further, heart attacks, 
s troke and suicide can lead to preemptive death. (adapted from Felitti et al. 1998). 
A strong dose-response relationship between adverse childhood experiences and the probability of 
lifetime or recent depressive disorders has also been reported by another study (Chapman et al. 2004). 
Childhood adversities also showed a graded relationship with suicide attempts; any adverse childhood 
experience increased the risk to attempt suicide by 2- to 5-fold (Dube et al. 2001). Concordant findings 
were also reported by the Ontario Health Survey (MacMillan et al. 2001). Conclusively, there is a strong 
association between early life adverse experiences and the development of depressive disorders in 
later life (Heim and Binder 2012). 
1.3 Genetic heritability of psychiatric disorders 
A large number of epidemiological studies support the genetic contribution to psychiatric disorders. 
Meta-analysis of twin studies estimated the genetic heritability of major depressive disorder to 37-
38% (Sullivan et al. 2000; Kendler et al. 2006). Interestingly, the heritability differed greatly between 
men and women with 29% and 42%, respectively (Kendler et al. 2006). In light of the high heritability, 
there was great anticipation in genome-wide association studies (GWAS) to unravel the genes 
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responsible for these common disorders. However, up to now, with the exception of schizophrenia, 
GWAS could not fulfil their promises (Figure 3).  
 
Figure 3: Number of genome-wide significant hits in GWAS studies for various psychiatric 
disorders in comparison to Crohn’s disease and inflammatory bowel disease. 
The number of genome-wide significant loci is plotted against the number of cases in genome-
wide association studies (GWAS). For psychiatric disorders, the number of identified genome-
wide significant hits is very low despite the high number of cases investigated. The only 
exception is schizophrenia (SCZ). BPD: bipolar disorder; MDD: major depressive disorder; ASD: 
autism spectrum disorder; ADHD: attention deficit hyperactivity disorder; Cross-disorder: broad 
psychiatric phenotype spanning ASD, ADHD, BPD, MDD, SCZ; SCZ-BPD, SCZ and BPD; AD: 
Alzheimer’s disease; CD-IBD: Crohn’s disease and inflammatory bowel disease; AN: anorexia 
nervosa; OCD: obsessive compulsive disorder; TS: Tourette’s syndrome. (modified from Gratten 
et a l . 2014) 
For MDD, a recent Chinese study confined to women with recurrent MDD detected two significant hits 
(Converge Consortium 2015) while other studies were lacking any significant hits at all (Ripke et al. 
2013). A possible explanation for the malperformance could be the high level of etiological 
heterogeneity among patients diagnosed with MDD. Additionally, the sample size (9240 MDD cases) 
was still far from the latest schizophrenia analysis which included 36,989 cases (Schizophrenia Working 
Group of the Psychiatric Genomics Consortium 2014). In the SCZ study, 108 genetic loci reached 
genome-wide significant levels (Figure 4) whereby 83 loci had not been reported previously. 
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Figure 4: Manhattan Plot of the latest GWAS for schizophrenia with 108 genome-wide significant loci. 
The distribution of genome-wide significant hits across the genome is plotted. The red line marks the level of genome-wide 
s ignificance (5×10-8). Green diamonds mark independent genome-wide significant index SNPs (Schizophrenia Working 
Group of the Psychiatric Genomics Consortium 2014). 
Comparisons between the GWAS of different psychiatric disorders revealed substantial SNP-based 
coheritabilities and correlations. The highest correlation has been reported between schizophrenia 
and bipolar disorder (0.68) followed by schizophrenia and major depressive disorder (0.43) and bipolar 
disorder and major depressive disorder (0.47) (Cross-Disorder Group of the Psychiatric Genomics 
Consortium 2013). Moreover, a pathway analysis including GWAS data from schizophrenia, bipolar 
disorder, and major depressive disorder found an accumulation of risk genotypes in specific biological 
pathways which overlap between these disorders (The Network and Pathway Analysis Subgroup of the 
Psychiatric Genomics Consortium 2015). These findings highlight common genetic influences across 
psychiatric disorders. 
1.4 Gene × environment interactions 
Beside genetic factors, another critical factor for the development of psychiatric disorders are 
environmental influences throughout life, especially in early life. The interplay between environmental 
and genetic influences ultimately determines an individual’s susceptibility to stressful experiences and 
thus their risk to develop psychiatric disorders. 
1.4.1 Windows of Sensitivity 
Every living being is exposed to various kinds of stressors throughout lifetime. These can differ in 
quantity and quality and are perceived differently on an individual basis. A healthy organism normally 
responds to these challenging situations with long-term and short-term physiological adaptions aiming 
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at reinstating homeostasis and preparing for further situations alike. However, there are periods in 
lifetime during which an organism is more susceptible to aversive exposures (Figure 5). Especially the 
brain passes through various critical periods prenatally and postnatally. Childhood as well as puberty 
comprise periods characterized by substantial rewiring and reorganization in the brain. Later in life, 
age-related mental decline can occur in adult and aged individuals.  
 
Figure 5: Windows of sensitivity and the accumulation of stress throughout life. 
Throughout life, humans face various s tressful life events. The impact of these events depends on the 
developmental s tage of the individual and shapes the responsiveness to later events. The brains capability 
to adapt to environmental cues by cellular and molecular plasticity declines over lifetime. On the other 
hand, stressful experiences accumulate. The predictive va lue of early l ife events is thus influencing the 
s tress-coping capability in later s tages (Zimmermann et a l. 2016). 
Developing brain regions are most vulnerable to stressful disturbances (Lupien et al. 2009). Both 
positive as well as negative aversive experiences can influence activity-dependent plasticity and lead 
to permanent structural changes in brain circuitry as well as regulatory differences (Katz and Shatz 
1996). Brain regions regulating HPA axis activity like the hippocampus, the frontal cortex, and the 
amygdala are especially affected by stress during their development in the perinatal period. In these 
brain regions, alterations can lead to long-lasting changes persisting into adulthood. The frontal cortex 
undergoes further major refinements during adolescence, which makes it sensitive to stressful 
experiences during this stage of life. Other brain regions, however, are more vulnerable to the effects 
of aging and thus affected by stress in later life. Vulnerability for stress-related disorders is therefore 
dependent on various experience-dependent adjustments throughout the brain in a stressor- and 
tissue-related manner (Murgatroyd and Spengler 2011). 
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1.5 Sex differences in psychiatric disorders 
Sex differences in the prevalence of psychiatric disorders, especially major depressive disorder, are 
well known (Dohrenwend and Dohrenwend 1976; Kessler et al. 1993; Weissman et al. 1993) . Overall, 
major depressive disorder was found to be twice as common in females compared to males (Figure 6). 
On the other hand, men are more severely affected by schizophrenia, attention deficit hyperactivity 
disorder, and autism (Holden 2005; Menger et al. 2010). Despite these differences between males and 
females, most studies, especially in animals, still fail to include females (Beery and Zucker 2011). 
 
Figure 6: Sex ratio of various psychiatric disorders. 
The incidence of various psychiatric disorders in females compared to males (=1) (modified from 
Holden 2005). 
Also on the molecular level, there are differences in the response to stress between sexes. For 
example, the brain circuits involved, the effects on synaptic and neuronal plasticity, and the cognitive 
and emotional behavioral effects differ (Hodes et al. 2015). Taken together, there are pronounced 
sexual differences in the stress response but neuroscience research has so far fallen short in examining 
the molecular underpinnings in much detail. 
1.6 Epigenetic modifications 
Although the DNA sequence of all somatic cells of an organism is the same, various developmental 
processes result in the manifestation of a vast variety of cell types. The so-called epigenetic 
mechanisms, which do not alter the DNA sequence but alter the accessibility and three dimensional 
structure of the genome, result in specific expression patterns determining individual cell identities 
(Armstrong 2014). Besides histone modifications, the so far best studied epigenetic mechanism is DNA 
methylation, which we will focus on herein. Other epigenetic mechanisms include microRNAs and 
other non-coding RNAs as well as chromatin remodeling factors (Allis et al. 2015). 
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1.6.1 DNA methylation 
DNA methylation is commonly referred to as the stable, covalent binding of a methyl group (CH3) at a 
cytosine nucleotide. It is best studied in the context of CpG dinucleotides, which are normally depleted 
from the genome but can also form stretches of relatively high abundance, so-called CpG islands 
(Jeltsch and Jurkowska 2014; Schübeler 2015). CpG islands are often found in promoter regions and 
generally remain methylation free, whereas other CpGs are mostly methylated (Saxonov et al. 2006; 
Gibney and Nolan 2010). With the advent of whole genome bisulfite sequencing, it has been 
established that also non CpG methylation is present on the genome, but its function still remains to 
be elucidated (Lister et al. 2013). 
DNA methyl transferases (DNMTs) catalyze the transfer of a methyl group onto the cytosine 
nucleotide. This family of enzymes is comprised of DNMT1, DNMT3A, DNMT3B, and DNMT3L (Ooi et 
al. 2009). DNMT1, the maintenance methyltransferase, recognizes hemimetylated DNA and ensures 
the conservation of methylation marks during DNA replication in the S phase. In contrast, DNMT3A 
and DNMT3B, the de-novo methyltransferases, recognize unmethylated DNA and catalyze new 
methylation marks in concert with other DNA binding proteins. One of these is DNMT3L, which has no 
catalytic activity itself but plays a role as scaffold (Kareta et al. 2006).  
DNA methylation is generally associated with transcriptional repression (Bell et al. 2011; Thurman et 
al. 2012). Recent studies have however shown that this does not hold true on a genome-wide level. 
The effect of DNA methylation strongly depends on the sequence context and can be associated with 
both repression and activation of gene expression (Weber et al. 2007; Lister et al. 2009, 2013; 
Maunakea et al. 2010). 
Historically, DNA methylation has first been studied in the context of imprinted genes, silencing of 
transposable elements, and cell lineage decisions (Hoffmann et al. 2015). However, the traditional view 
of DNA methylation as a stable modification which is established during differentiation had to be 
revised due to the recent discovery of active demethylation (Wu and Zhang 2014). Accordingly, DNA 
demethylation cannot only occur passively during cell division but also in mature cells like neurons.  
The core of the demethylation machinery is comprised of the ten-eleven translocation (Tet) family of 
enzymes (TET1-3). These enzymes catalyze the stepwise oxidation of 5-methylcytosine (5mC) to 5-
hydroxymethylcytosine (5hmC) (Tahiliani et al. 2009; Ito et al. 2010) and further to 5-formylcytosine 
(5fC) and 5-carboxylcytosine (5caC) (He et al. 2011; Ito et al. 2011) (Figure 7). These oxidation products 
can then be recognized by various other enzymes. 5hmC can be directly deaminated by AID/APOBEC 
proteins, which generates 5-hydroxyuracil (5hmU). On the other hand, 5fC and 5ca are excised by the 
DNA glycosylase TDG (thymine DNA glycosylase). The enzymes of the base excision and/or nucleotide 
excision repair machinery (BER/NER) are then repairing the DNA at this position (Cortellino et al. 2011).  
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Figure 7: Iterative cycles of methylation and active 
demethylation. 
Cytos ine (C) nucleotides are methylated by DNA 
methyltransferases (DNMTs). Active demethylation by ten-eleven 
trans location (Tet) enzymes proceeds from 5-methylcytosine 
(5mC) via  5-hydroxymethylcytosine (5hmC) and 5-formylcytosine 
(5fC) to 5-carboxylcytosine (5caC). These cytosine derivatives are 
deaminated to thymine, removed by thymine DNA glycosylase 
(TDG) and subsequently repaired by the  base excision and/or 
nucleotide excision repair machinery (BER/NER) (Zimmermann et 
a l . 2015). 
It has been proposed that not only methylation but also hydroxymethylation and its derivatives at 
cytosine nucleotides have various functions. They are present at regulatory sites throughout the 
genome (Lister et al. 2013) and specific reader proteins have been found for each of them (Spruijt et 
al. 2013). In summary, DNA methylation is a dynamic epigenetic mark, which is involved in many 
different processes. Active demethylation as well as the recruitment of specific reader and effector 
proteins is involved in its regulation. 
1.7 The HPA axis 
The hypothalamic-pituitary-adrenal (HPA) axis is well known for its central role in the neuroendocrine 
stress response. It is activated by a broad variety of physiological and psychological stressors and 
coordinates the cognitive, behavioral, and metabolic stress response of the organi sm. Extrinsic and 
intrinsic stressors trigger the release of corticotropin-releasing hormone (CRH) and arginine 
vasopressin (AVP) from the paraventricular nucleus (PVN) of the hypothalamus (Figure 8).  
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Figure 8: The hypothalamic-pituitary-adrenal axis. 
Upon stress, corticotropin-releasing hormone (CRH) is released 
from the paraventricular nucleus (PVN) which results in the 
release of adrenocorticotropic hormone (ACTH) from the 
pi tuitary. ACTH stimulates the release of glucocorticoids from 
the adrenal cortex. Negative feedback by glucocorticoids occurs 
in the hippocampus, the PVN and the pituitary. 
CRH and AVP are transported through the median eminence to the anterior pituitary where they bind 
their respective receptors. This triggers transcription of pro-opiomelanocortin (POMC) which is 
processed postranslationally to adrenocorticotropic hormone (ACTH). ACTH binding at the adrenal 
cortex, in turn, stimulates the production and secretion of glucocorticoids (cortisol in humans and 
corticosterone in humans, rats, and mice). These glucocorticoids orchestrate the bodies peripheral 
stress response, which includes the release of glucose from the liver and the suppression of the 
immune system. However, the stress response is tightly regulated by a negative feedback loop at 
pituitary, hypothalamic and hippocampal levels. There, glucocorticoids bind to the respective 
receptors, glucocorticoid receptor (GR) and mineralocorticoid receptor (MR), and reinstate the 
homeostatic equilibrium by shutting down the stress response (de Kloet et al. 2005). 
Introduction 
12 
1.8 Stress related disease models in rodents 
The molecular and behavioral effects of stress are well studied in rodents by a wide variety of models. 
This includes both the time of stress (prenatal, postnatal, adult) and the duration (acute or chronic) of 
the stress as well as a combination of them. Since the CRH gene is one of the main effectors of the 
stress response, its promoter methylation and RNA expression has been investigated in several 
different animal models (Figure 9). Conclusively, epigenetic programming of CRH expression occurs in 
a stressor-, sex-, and tissue-specific manner (Raabe and Spengler 2013). 
 
Figure 9: Different experimental stress responses in rodents and their influence on CRH promoter methylation and RNA 
expression. 
Mice and rats were exposed to different stress paradigms at different times of age. CRH promoter methylation and 
expression changes in the paraventricular nucleus (PVN) and the central amygdala (CeA) are depicted by arrows. ♂: male; ♀: 
female; n.d.: not determined (Raabe and Spengler 2013). 
1.8.1 Animal models of early life stress 
Since the postnatal period is critical for the development and maturation of various brain regions like 
the hippocampus, experimental manipulations in this period are often used to study the long-term 
consequences of stress exposure (Lucassen et al. 2013). Figure 10 summarizes the most common 
paradigms to induce early life stress in rodents. 
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Figure 10: Different paradigms to induce early life stress in 
rodents. 
A: exposure of the pregnant dam to repeated s tress; B: a  single 
separation of dam and pups for 24 hours; C: da ily separation of 
dam and pups for 2-5 hours; D: reduced nesting and bedding 
material; E: selection of the dam based on the natural variation 
in maternal care (Lucassen et al. 2013). 
The overarching principle underlying all these experiments is the alteration of maternal sensory input 
and care. This includes a disturbed dam-pup interaction, which also affects other key components like 
warmth, nutrition, and social interaction. Overall, lasting effects of these manipulations on brain 
structure and function could be shown. 
1.8.1.1 Maternal separation 
The first of the two early life stress models used in this study was maternal separation. Maternal 
separation is a well-established model to induce early life stress in rodents and consists of daily 3h 
separation of the pups from the dam for the first 10-14 days of their life (Pryce and Feldon 2003; 
Millstein and Holmes 2007). In previous studies, we could already show that early life stress in C57BL/6 
mice induces long-lasting changes on all levels of the HPA axis (Murgatroyd et al. 2009; Wu et al. 2014; 
Bockmühl et al. 2015). 
1.8.1.2 Limited nesting material 
The second mouse model for early life stress used in this study was the limited nesting and bedding 
material paradigm. It was first established in rats (Gilles et al. 1996; Ivy et al. 2008) and later transferred 
to mice (Rice et al. 2008). In both species, a fragmented maternal care was shown to increase 
corticosterone levels in the pups with long-lasting consequences on CRH expression. In contrast to 
maternal separation, the overall amount of maternal care is not changed in this paradigm but is rather 
fragmented and unpredictable. Thus, it might closer resemble the human situation (Molet et al. 2014). 
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1.8.2 Modeling adult life adversities 
In order to test the programming effects of early life stress, mice can be exposed to a second stressor 
in adulthood. The possible variations of adult stress are numerous, therefore, only the paradigms 
selected herein will be shortly described. 
1.8.2.1 Pharmacological intervention 
As a partial surrogate of stress, the injection of corticosterone was chosen in adult mice. Corticosterone 
was preferred to dexamethasone due to its capability to cross the blood brain barrier. Moreover, 
corticosterone is the natural ligand to the glucocorticoid receptor in contrast to the synthetic 
glucocorticoid dexamethasone. 
1.8.2.2 Chronic social defeat stress 
The chronic social defeat stress paradigm has been well characterized and validated within and outside 
the institute (Berton et al. 2006; Kinsey et al. 2007; Haenisch et al. 2009; Wagner et al. 2011; Balsevich 
et al. 2014). Generally, mice are exposed to an aggressive, dominant resident mouse, often 
represented by a CD1 mouse. After the mouse has been defeated, it is separated from the aggressor 
but still stays in sensory contact. This is applied either as single defeat stress or chronically for a varying 
number of days. When defeated chronically, each day an unfamiliar aggressor is presented. Chronic 
social defeat creates a persistent emotional stress without habituation and results in persistent social 
avoidance (Hollis and Kabbaj 2014). 
1.8.3 The match mismatch hypothesis of cumulative stress 
There are two prominent hypotheses about the interaction of stressful events throughout life which 
are partly conflicting each other. The cumulative stress hypothesis, also called two-hit model, suggests 
that stressful events in early life predispose for pathological outcomes of adult stress or, generally, 
that more stress exposure leads to worse outcomes (Walker et al. 2009; Taylor 2010). In contrast, the 
mismatch hypothesis states that harsh environments in childhood can prepare for adult stress. 
Therefore, individuals which experienced stressful situations during early  life are better off than non-
stressed counterparts when facing adverse situations in adulthood. Thereby, the consequences of 
stressful life events are rather a matter of correct forecast and adaption then the actual stressor 
(Schmidt 2011; Frankenhuis and Del Giudice 2012). Supportive evidence for this hypothesis could 
already be gained in our institute (Santarelli et al. 2014). 
Even though the two hypothesis seem to be mutually exclusive there has been an effort to reconcile 
them (Nederhof and Schmidt 2012). A third dimension, in addition to early and adult stress, the 
programming sensitivity of an individual, has been hypothesized. This variable means that the 
individuals’ ability to respond and adapt to environmental cues is taken into account. Consequently, 
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individuals with high programming sensitivity would benefit from matching environments even if they 
were aversive. On the other hand, individuals with low programming sensitivity are not able to adapt 
to early life adversities and thus have problems dealing with stress in adulthood.  
1.9 Bioinformatics methods 
1.9.1 Batch correction analysis 
The consequences of batch effects in high throughput technologies are often underestimated. Batch 
effects occur for example when subsets of an experiment are performed by a different experimenter, 
on different days, or with a new lot of reagent. In contrast to low throughput experiments, where batch 
effects also occur, the data quantities of high throughput technologies like next generation sequencing 
allows to detect them and correct for it (Leek et al. 2010). Batch effects are avoided by randomization 
but the full extent of technical and biological artifacts cannot be rigorously determined. Therefore, 
various methods to correct for batch effects have been established, including surrogate variable 
analysis (SVA) (Leek and Storey 2007). SVA seeks to detect expression heterogeneity, which are 
patterns of variation due to an unmodeled factor, within the expression data and estimates surrogate 
variables correcting for it. Thereby, not only the disturbances by known factors like age, gender, or 
extraction date can be identified and resolved but unknown factors or interactions between factors as 
well. The surrogate variables can then be used as covariates in the differential expression 
determination. In alternative to the SVA, the use of another batch correction method called ComBat is 
possible. ComBat removes technical batches known to the user, but only one at a time. Moreover, the 
batch that should be removed has to be protocolled within the experiment and thus be known to the 
experimenter. This is not always the case since sometimes small but recurrent technical variations or 
some biological properties are not completely documented. SVA is superior in this case since it predicts 
batches from within the data. This, on the other hand, results in the possibility of overcorrection. An 
unbiased data exploration outside of the experimental question is not possible after such corrections 
(Jaffe et al. 2015).  
1.9.2 Differential gene expression analysis 
Differential gene expression analysis was conducted with TruSeq® Targeted RNA sequencing (2.2.7). 
The advantage of this method is the relative time and cost efficiency when compared to standard 
methods like qPCR and RNA sequencing. qPCR analysis is advantageous when comparing a limited 
number of genes (1-10) in a large number of samples. With RNA sequencing, on the other hand, the 
whole transcriptome is sequenced but the number of samples that can be analyzed is limited by the 
high costs per sample. With TruSeq® Targeted RNA sequencing, the advantages of both methods are 
combined. Frequently, a subset of genes e.g. a specific pathway or specific marker genes (around 100 
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genes) are determined by previous experiments. Thus, it is not necessary to sequence the whole 
transcriptome; however, a large number of samples is analyzed. In this case, TruSeq® Targeted RNA 
sequencing offers the possibility to sequence a customized set of genes (12-1000) in up to 384 samples 
at once.  
The data gained by TruSeq® Targeted RNA sequencing is represented in counts per transcript. 
Therefore, standard methods from RNA sequencing can be adapted. In both cases, the number of 
sequencing reads that correspond to the transcript of a known gene are counted. Subsequently, 
differences in the quantity of sequenced transcripts, the gene expression level, are compared between 
experimental groups (Anders et al. 2013). The analysis of count data is well established and has been 
proposed to be best modeled by a negative binomial distribution (Whitaker 1914). There have been 
several R packages developed which facilitate the differential expression analysis of sequencing count 
data: DESeq (Anders and Huber 2010) and its successor DESeq2 (Love et al. 2014) as well as edgeR 
(Robinson et al. 2010). These are the most popular ones and all  belong to the Bioconductor software 
development project (Gentleman et al. 2004). Beside these sophisticated packages there are also the 
basic functions for linear models lm() from the stats package (Chambers and Hastie 1993) as well as 
the generalized linear model with negative binomial distribution glm.nb() in the MASS package 
(Venables and Ripley 2002). The use of these basic functions offers the possibility to adjust the 
analyzing process dependent on the available data and specific needs of the researcher e.g. the 
combination with the aforementioned batch correction methods.  
1.9.3 Network analysis - partial correlation co-expression networks 
Gene co-expression networks are a straightforward representation of the functional connectivity of 
genes. Network nodes represent genes and edges connect genes which are significantly co-expressed 
(Zhang and Horvath 2005). Co-expression of genes has been shown to be tightly connected to 
functional similarity (Eisen et al. 1998). Thus, co-expression networks can provide insight into cellular 
processes that require orchestrated gene expression. 
To measure the co-expression between any two genes the Pearson correlation coefficient is generally 
used. Genes are connected by edges if the coefficient exceeds a specific threshold, this results in a so 
called “relevance network”. However, a correlation between two genes can result from several 
associations in this scenario. Genes can be in direct or indirect interaction or can be regulated by a 
common gene (Schäfer and Strimmer 2005). Thus, it is more appropriate to use the partial correlation 
coefficient, which depicts only direct interactions. Partial correlation quantifies the correlation 
between two genes (A and B) while conditioning for one or more other genes (X, Y,  Z, …). The 
correlation of other genes is regressed out from the correlation between A and B, thus the partial 
correlation between A and B is the part of gene expression which is uncorrelated with other genes 
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(Fuente et al. 2004). This idea is implemented by graphical Gaussians models (GGMs) (Dempster 1972). 
GGMs depict only direct edges in an undirected manner between the genes. The R package GeneNet 
uses GGMs to infer gene association networks which allow the identification of co-regulated genes 
(Schaefer et al. 2015). 
1.10 GR-response eQTLs associated with major depressive disorder  
In a recent study, Arloth et al. investigated the influence of single nucleotide polymorphisms (SNPs)  on 
GR target gene activation on a genome-wide level. In their study, 160 male individuals were 
administered dexamethasone, a synthetic glucocorticoid, to measure the genome-wide activation of 
target genes in a genotype dependent manner. Blood samples were taken before and 3 hours after 
dexamethasone application and genome-wide gene expression was measured by microarray analysis. 
Additionally, DNA was extracted for genome-wide genotyping. The combination of these data allowed 
the identification of GR-response cis-eQTLs, which are SNPs regulating the GR-dependent activation of 
a gene in a genotype specific manner (Figure 11).  
 
Figure 11: Flow chart summarizing the experimental setup and analysis conducted in 
the study by Arloth et al. 
GR-response expression quantitative tra it loci (eQTLs) are identified in whole blood of 
human males and prioritized by mapping to nominally s ignificant loci from genome 
wide association studies (GWAS) for major depressive disorder and schizophrenia 
(SCZ) (adapted from Arloth et al. 2015). 
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These SNPs were then matched with data from genome-wide association studies (GWAS). GWAS for 
major depressive disorder (MDD) have so far detected genome-wide significant signals only with 
limited success (Ripke et al. 2013; Converge Consortium 2015). Therefore, nominally significant hits 
(p≤0.05) from Ripke at al. were matched with the identified GR-response eQTLs to obtain 23 MDD-
related GR eSNPs. These 23 MDD-related GR-response eQTL genes formed a tightly connected co-
expression network (Arloth et al. 2015). 
1.11 Aim of the study 
Early life stress is a well-established risk factor for depressive disorders later in life. In this study, we 
wanted to dissect the molecular underpinnings of this relationship with the help of mouse models for 
depressive disorders on the epigenetic as well as the genetic level (Figure 12). 
 
Figure 12: Conceptual framework of the study. 
The development of depressive disorders is influenced by early life s tress that alters the 
hypothalamic–pituitary–adrenal (HPA) axis responsiveness via epigenetic programming. 
Additionally, genetic factors influence the ri sk of developing psychiatric disorders. Here, 
the interplay between depressive disorders and early l ife s tress has been investigated on 
both the epigenetic as well as the genetic level. The first part focuses on epigenetic 
programming of CRH; the second part investigates the regulation of MDD/SCZ-related GR-
response eQTLs. 
In the first part, we applied a candidate approach. As the HPA axis is the major stress response system, 
we investigated one of its main stress hormones, CRH. Previous studies have already shown that AVP, 
which works in concert with CRH, is epigenetically programmed by early life stress (Murgatroyd et al. 
2009) as well as its downstream target POMC (Wu et al. 2014). Further, also the glucocorticoid receptor 
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gene, which plays an important role in the negative feedback control of the HPA axis, has been shown 
to be epigenetically programmed in response to early life stress (Bockmühl et al. 2015). In this line, 
CRH expression and methylation were investigated in adult mice with a history of maternal separation. 
In the second part, the gene expression of previously identified eQTL genes was investigated. Based 
on the study by Arloth et al. (2015) we evaluated the properties of the psychiatric disorders-related 
GR-response eQTL network in two related mouse models of ELS. The use of these experimental models 
allowed us manipulations at specific time-points and access to brain tissue. With the help of a new 
technique, TruSeq® Targeted RNA sequencing, we could pursue an unbiased approach and investigate 
the expression of the identified eQTL genes in a multitude of stress related brain regions. Further, the 
long-term effects of early life stress, alone and in conjunction with an adult stressor, could be 
evaluated. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Equipment  
Name Model Manufacturer 
Bioanalyzer 2100 Agilent 
Cryostat  CM3050S Leica 
Desktop Sequencer MiSeq Illumina 
Dual channel liquid swivel  TCS2-23 Eicom 
FEP tubing i.d. 0.15±0.05 mm Microbiotech/se AB 
Fluorometer Qubit 3.0 Invitrogen 
Gel Documentation System  UVT 2035 Herolab 
LightCycler 2.0 Roche 
Liquid scintillation counter LS 6000IC Beckmann 
Microcentrifuge  Microfuge 18 Beckman Coulter 
Microcentrifuge (cooling) 5415R Eppendorf 
Microsampler 820 Univentor 
NanoPhotometer P-300 Implen 
pH-Meter  inoLab ph720 WTW  
Precision Balance  PM2500 DeltaRange Mettler Toledo 
Real Time PCR MiniOpticon™ MJ mini Biorad 
Scanner CanoScan 9950F Canon 
SmartSpec Plus 
Spectrophotometer 
170-2525 Biorad 
Thermocycler  TGradient 96 Biometra 
Thermomixer  Compact Eppendorf 
Ultrapure Water System  PURELAB Ultra ELGA LabWater 
Vortexer MS2 minishaker IKA 
Table 2: Equipment 
2.1.2 Chemicals and consumables 
Name Provider Cat. Number 
0.1 cm Gene Pulser Cuvette Biorad 165-2083 
1kb Plus DNA Ladder  Invitrogen 10787-026 
2-propanol Roth 6752 
300 µl microtubes  Microbiotech/se AB 4001048 
5-Bromo-4-chloro-3-indolyl β-D-galactopyranoside  
(X-Gal) 
Sigma B4252 
Acetic anhydride Sigma A6404 
Agar Roth 5210.2 
Agarose PeqLab 35 1020 
BioMax MR film 30x40 cm Kodak 8929655 
Bio-Spin® Columns with Bio-Gel® BioRad 732-6002 
Bromophenol Blue Sigma B0126 
Chloroform Sigma C2432 
Materials and Methods 
21 
Corticosterone: HBC complex Sigma C174-100MG 
Cover slips  DURAN Group 23 550 34 
Cresyl Violet acetate Sigma C5042 
Denhardt’s Solution 50x Sigma D2532 
Dextran sulfate Sigma D8906 
Dimethyl sulfoxide (DMSO) Sigma D8418 
di-Potassium hydrogen phosphate trihydrate (K2HPO4 x 
3H2O) 
Roth 6878 
di-Sodium hydrogen phosphate dihydrate (Na2HPO4 x 
2H2O) 
Merck 106576 
Dithiothreitol (DTT) Sigma D9779  
DNA Sigma D7656 
dNTPs Thermo Scientific R0181 
Ethanol Merck 100983 
Ethylenediamine tetraacetic acid disodium salt 
dihydrate (EDTA) 
Roth X986 
Formaldehyde Sigma F8775 
Formamide Fluka 47670 
Glycerol Roth 3783 
Glycogen Roth HP51 
Insulin Syringe BD 320801 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Sigma I6758 
Metacam® (5mg/ml) Boehringer Ingelheim GmbH 
Microdialysis CMA 11 Guide Cannula CMA 8309018 
Microdialysis Probe (11 Metal Free) CMA 8011083 
Microvette 200 EDTA Tubes Sarstedt 20.1288 
NucleoFast® 96 PCR Plates Macherey Nagel 743100 
Optitran® nitrocellulose membrane Whatman 10 439 196 
Pattern Resin LS GC America 335201 
Phenol/chloroform/isoamylalcohol Roth A156 
Potassium chloride (KCl) Sigma P9541 
Potassium dihydrogen phosphate (KH2PO4) Merck 104873 
Protein Assay Dye Reagent Concentrate BioRad 500-0006 
Protein marker Fermentas SM 1811 
Sodium chloride (NaCl) Roth 9265 
Sodium dodecyl sulfate (SDS) Sigma 436143 
ß-mercaptoetanol Sigma 63689 
Superfrost™ Plus microscope slides  Thermo Scientific J1800AMNZ 
Tissue Freezing Medium Leica 14020108926 
Triethanolamine (TEA) Sigma T1377 
tri-Sodium citrate dihydrate (Na3C6H5O7x2H2O) Roth HN12 
Triton X-100 Roth 3051.3 
TRIzol® Reagent Invitrogen 15596-018 
Tryptone/Peptone Roth 8952.2 
Tween 20 Roth 9127.1 
Uridine 5´-(α-thio) triphosphate [35S] Perkin Elmer NEG-039H 
Xylene cyanol FF Sigma X4126 
Yeast extract Roth 2363.2 
Yeast total RNA Sigma R6750 
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Yeast tRNA Sigma R9001 
Table 3: Chemicals and consumables 
2.1.3 Enzymes 
Name Provider Cat. Number 
ABsolute Blue qPCR SYBR Green Thermo Scientific AB 4166 
DNA Polymerase I, Large (Klenow) Fragment Invitrogen 18012-021 
FastAP Thermosensitive Alkaline Phosphatase Thermo Scientific EF0654 
HotStarTaq® Plus Qiagen 203601 
Proteinase K Sigma P2308 
Restriction enzymes Fermentas/New England Biolabs 
RevertAid Premium Reverse Transcriptase Thermo Scientific EP0731 
RiboLock RNase Inhibitor Thermo Scientific E00382 
RNAse A AppliChem A2760,0100 
RQ1 RNase-Free DNase Promega M 6101 
T4 DNA Ligase Fermentas EL0014 
T4 Polynucleotide Kinase Fermentas EK0031 
Taq DNA Polymerase Thermo Scientific EP0403 
ProtoScript® II Reverse Transcriptase New England Biolabs M0368 
Table 4: Enzymes 
2.1.4 Buffers and solutions 
Name Composition 
10x PBS  NaCl (1.37 M)    80 g 
KCl (27 mM)    2 g 
KH2PO4 (20 mM)   2.7 g 
Na2HPO4 x 2H2O (100 mM)  17.8 g 
DEPC-Water, fill up to   1000 ml 
20x SSC NaCl     175.3 g 
Na citrate (Na3C6H5O7x2H2O)  88.2 g 
Dissolve in 800 ml water, adjust pH 7.0 with HCl and fill up to 1 L with 
a.d. 
SOB Medium Tryptone     20 g 
Yeast extract     5 g 
NaCl (5 M)     2 ml 
KCl (2.5 M)     1 ml 
DEPC-Water, fill up to   1000 ml 
LB-Agar Tryptone     20 g 
Yeast extract    5 g 
NaCl (5 M)     2 ml 
KCl (2.5 M)     1 ml 
Agar     15 g 
DEPC-Water, fill up to   1000 ml 
TB medium Tryptone     12 g 
Yeast extract     24 g 
Glycerol    0.4% (v/v) 
KH2PO4     2.3 g 
K2HPO4 x 3H2O     16.4 g 
IPTG/X-Gal solution H2O     105 µl 
DMSO     40 µl 
IPTG (0.1 M)    30 µl 
Materials and Methods 
23 
X-Gal (10%)    25 µl 
6x DNA loading dye bromophenol blue (0.25%)  0.25 g 
xylene cyanol (0.25%)   0.25 g 
sucrose (40%)    40 g 
ddH2O     100 ml 
2 x Hybridization buffer 5 M NaCl    4.8 ml 
1 M Tris, pH 7.5    0.400 ml 
0.5 M EDTA, pH 8.0   0.080 ml 
Sheated and boiled DNA (10 mg/ML) 0.400 ml 
(denaturate 5 min @ 90°C) 
Yeast total RNA (20 mg/ml)  1.0 ml 
Yeast tRNA (50 mg/ml)   0.080 ml 
Denhardt´s solution 50x   0.800 ml 
Dextran sulfate 50%    8.0 ml 
Sterile water    4.44 ml 
 Aliquot and store at –70°C 
RNAse buffer 5 M NaCl    200 ml 
1 M Tris-HCl, pH 8.0   20 ml 
0.5 M EDTA, pH 8.0   4 ml 
DEPC-Water    1776 ml 
Artificial cerebrospinal 
fluid (CSF) 
145 mM NaCl    4.2370 g 
2.7 mM KCl    0.1005 g 
1.2 mM CaCl2 2 H2O   0.0880 g 
1.0 mM MgCl2 6 H2O   0.1015 g 
2.0 mM Na2HPO4   0.1420 g 
pH=7.4     in 500 ml H2O 
Cresyl Violet Solution 1 g cresyl violet acetate (Sigma) 
100 ml H2O 
0.25 ml acetic acid 
Mix for 1h 
filter 
Table 5: Buffers and solutions 
2.1.5 Molecular biology kits 
Name Provider Cat. Number 
Corticosterone RIA (Rat, Mouse) DRG Diagnostics ria-1364 
Corticosterone RIA (Rat, Mouse) MP Biomedicals 07120103 
EpiTect® Bisulfite Kit Qiagen 59104 
LightCycler® FastStart DNA MasterPLUS SYBR Green I Roche 03 515 869 001 
miRNeasy Mini Kit Qiagen 217004 
NucleoBond PC100 Macherey Nagel 740573 
NucleoSpin® Plasmid Macherey Nagel 740.588.250 
NucleoSpin® Extract II Kit Macherey Nagel 740.609.250 
PAXgene Blood RNA Kit PreAnalytiX 762174 
pGEM®-T Vector System Promega A3600 
Riboprobe® Combination System-SP6/T7 RNA Polymerase Promega P1460 
RNeasy Mini Kit Qiagen 74104 
Table 6: Molecular biology kits 
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2.1.6 Primer and oligonucleotides 
2.1.6.1 qPCR primers 
Gene Froward Reverse 
CRH GCGGGCTCACCTACCAAG TTCTTCACCCATGCGGATCAG 
HPRT ACCTCTCGAAGTGTTGGATACAGG CTTGCGCTCATCTTAGGCTTTG 
MAS TATTGGCCCAGAGTATCAGCA GGGGTTTGTCGATGACTTCAA 
Table 7: qPCR primers 
2.1.6.2 Bisulfite specific primers 
Position Froward Reverse 
CRH Promoter TGTTAATGGATAAGTTATAAGAAATT ACTCTAAATTTCTCCACACCAAAACCTA 
Table 8: Bisulfite specific primers 
2.1.7 Software 
Name Manufacturer 
BioEdit Tom Hall, Ibis Biosciences 
DesignStudio Illumina 
FV10-ASW 4.0 Viewer Olympus 
GIMP The GIMP Team 
Illumina Experiment Manager Illumina 
ImageJ Schneider et al. (2012) 
Inkscape 0.91 Free Software Foundation, Inc. 
MiSeq Reporter Illumina 
Opticon Monitor 3 Bio-Rad 
Roche qPCR Roche 
RStudio with R 3.2.3 RStudio, Inc. 
SigmaPlot 12.5 Systat Software GmbH 
Vector NTI Invitrogen 
Table 9: Software 
2.2 Methods 
2.2.1 Animal experiments 
All procedures on animals were approved by the Regierung von Oberbayern, filed under reference 
number 55.2-1-54-2532-114-2013, and were in conformity with European Union Directive 
2010/63/EU. Standard laboratory animal housing conditions were maintained throughout the 
experiments, with 3–4 mice per cage and 12 h daily illumination (lights on at 06:00 a.m.). 
2.2.1.1 Early life stress 
The well-established paradigm of maternal separation was used to induce early life stress (Plotsky and 
Meaney 1993; Murgatroyd et al. 2009). Time-pregnant C57BL/6N mothers were purchased from 
Charles River. Maternal separation was conducted from postnatal day (PND) 1-10. Pubs were placed 
in new clean cage for 3h daily, the mother was left undisturbed in her home cage. Control pups were 
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reared under normal facility conditions. Pups remained with their mothers until weaning (PND21), 
when they were housed in sex-matched groups. 
2.2.1.2 Determination of the estrous cycle stage  
In order to determine the estrous cycle stage of female mice, cytological examination of vaginal smears 
was used. Vaginal fluid was collected using an inoculation loop filled with water. The inoculation loop 
was inserted into the vagina of the loosely fixed mice and vaginal secretion was carefully collected. The 
fluid was placed on glass slides and air dried. For staining, a solution of 1% methylene blue was used. 
The slides were dipped in the solution for 10 seconds and subsequently rinsed several times in water. 
The different cellular composition of vaginal secretion was analyzed under a light microscope with 40x 
magnification. Typical cellular compositions indicative of the respective cycle stage are illustrated in 
Figure 13. 
 
Figure 13: Light microscopy of vaginal smears stained with methylene blue. 
The typical cellular composition during the estrous phases in mice are shown. Leucocytes (L), intermediate cell (I), cornified 
cel l  (C), parabasal cell (P), and superficial cell (S) are indicated (Yener et al. 2007). 
A diestrus smear consists predominantly of leucocytes, often almost exclusively but epithelial cells can 
also still be present. In proestrus, round nucleated epithelial cells prevail, often in clusters. Anucleated 
cornified cells are present in estrous which normally last 1 day but can also extend for 2 days. 
Metestrus is characterized by the same proportion of leucocytes, cornified and nucleated epithelial 
cells (Yener et al. 2007; Goldman et al. 2007). Vaginal smears were analyzed directly after they were 
taken. The smears were collected every morning for at least one week before sacrificing the animals 
in order to assure the correct cycle stage. When estrus or diestrus stage was determined, the 
respective animals were sacrificed the same morning. 
2.2.1.3 Tissue preparation 
Mice were sacrificed at 3 month of age by rapid decapitation. Mouse brains were dissected  from the 
scull and snap-frozen in isopropanol (2-propanol) at -80°C.  
For in-situ hybridization, frozen brains were sectioned (10 µm) at the level of the PVN under 
histological control using a cryostat. The sections were collected on microscope slides and stored at -
20°C until further use. From the same brains, micropunches were collected with a 0.5 mm diameter 
punching needle from the brain regions relevant to the specific project under histological control by 
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cresyl violet staining according to the Mouse Brain Atlas (Paxinos and Franklin 2001) and immediately 
stored at -80°C. 
2.2.1.4  Limited nesting material – chronic social defeat stress mice 
Frozen brain samples were kindly provided by Sara Santarelli and Mathias V. Schmidt (Santarelli 2015). 
2.2.2 Molecular Biology 
2.2.2.1 RNA extraction with RNeasy and miRNeasy 
Frozen micropunches from the collected brain regions were lysed immediately in 500 µl Trizol (QIAzol) 
reagent and the tissue was homogenized by passing through an insulin syringe (29 G) several times. 
Subsequently, the samples were incubated at room temperature for a minimum of 3 min before 
adding 100 µl chloroform. The remaining steps were performed according to the manufacturer’s 
protocol. For RNeasy, an equal amount of 70% ethanol was added to the aqueous phase and for 
miRNAeasy 1.5 volumes of 100% ethanol were added. Elution was performed with 30 µl RNase-free 
water with a second elution step using the eluate from the first elution.  
2.2.2.2 RNA extraction from mouse trunk blood samples with PAX solution 
In order to be able to compare the results from human blood samples with mouse blood samples, a 
modified protocol of the human PAXgene blood RNA extraction was used. At least 250 µl of mouse 
trunk blood were collected in a 1.5 ml Eppendorf tube. Immediately, 2.76 volumes of PAX RNA 
stabilizer reagent were added to the blood and the tube inverted several times. Tubes were stored at 
room temperature for at least 2 h but up to 24 h before being stored at -20°C. Further steps were 
performed according to the manufacturers’ protocol  using the PAXgene Blood RNA Kit with minor 
modifications. Incubation at the 55°C shaker was prolonged to 60 minutes and elution was performed 
with two times 50 µl elution buffer (Krawiec et al. 2009). 
2.2.2.3 Plasmid DNA: mini preparations 
A single bacterial colony was picked with a sterile tip and inoculated in 2-3 ml SOB (Super Optimal 
Broth) medium with ampicillin (100-200 μg/ml). The culture was grown for 16 h at 37°C with vigorous 
shaking before harvesting in in 1.5 ml reaction tubes by centrifugation (14000 rpm/ 1 min/ 4C°). The 
plasmid DNA was isolated using the NucleoSpin® Plasmid Kit (Macherey-Nagel) according to the 
manufacturer’s instructions. 
2.2.2.4 Plasmid DNA: maxi preparations 
40 ml TB (Terrific Broth) medium was inoculated with a 2 ml aliquot of a bacterial preculture and was 
grown at 37°C for 16 h. Plasmid DNA was isolated and purified according to the NucleoBond PC100 
(Macherey Nagel) kit manufacturer’s protocol. After precipitation with isopropanol, the pellet was 
dissolved in 200 μl ddH2O and extracted by phenol/chloroform. Therefore, one volume of 
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phenol/chloroform/isoamylalcohol (25:24:1) was added and vortexed vigorously. After full speed  (≥ 
15000×g) centrifugation for 3 min at 4°C the supernatant was collected into a new tube, mixed with 
an equal volume of chloroform/isoamylalcohol (24:1) and centrifuged as before. The supernatant was 
again collected, mixed with chloroform/isoamylalcohol (24:1) and centrifuged. The supernatant was 
collected, precipitated with ethanol (2.2.2.5) and resuspended in 100 µl TE-buffer. The DNA 
concentration was measured using a SmartSpec Plus Spectrophotometer and adjusted to 1 µg/ml. 
2.2.2.5 Ethanol precipitation 
For ethanol precipitation 2 volumes 99% ethanol with 1/10 volume 3M NaAc and 1/10 volume 
glycogen (10 mg/ml) were added to 1 volume of reaction. This was mixed thoroughly by vortexing for 
1 min and subsequently frozen in liquid nitrogen for 1 min. After centrifugation for 20-30 min at full 
speed (≥ 15000×g) the supernatant was removed and 300 µl of 70% ethanol added. After another 
centrifugation for 5-10 min at full speed, the pellet was air dried at 65°C for 5 min. Finally, the DNA 
was respuspended in 5-10 µl H2O. 
2.2.2.6 Restriction digest of plasmid DNA 
Plasmid DNA was cut at selected restriction sites using various restriction enzymes (10 U/µl). Typically, 
reactions were either 5-25 µg DNA in 50 µl with 2-3 µl restriction enzyme or 300-500 ng DNA in 10 µl 
with 0.5 µl restriction enzyme. The buffers were chosen according to the manufacturer’s instructions. 
When double digest was performed, the DoubleDigest Calculator1 was used. When necessary the 
vector was simultaneously dephosphorylated by adding FastAP Thermosensitive Alkaline Phosphatase. 
2.2.2.7 Transformation of DH5α bacteria 
An aliquot of 50 μl electrocompetent DH5α E.coli cells was thawed on ice and  diluted with 100 μl ice 
cold ddH2O. An appropriate amount of DNA, either the whole ethanol precipitated ligation mix (5 µl) 
or 1 ng of purified plasmid of interest, were mixed with 45-50 μl of diluted bacteria and incubated on 
ice for 1 min. The transformation mix was transferred into an ice cold Gene Pulser Cuvette (Biorad) 
and incubated for 1 min at RT. Bacteria were transformed at 1.5 kV, 200Ω, 2.5 μF. Immediately after 
pulse delivery, 700 µl of SOB medium were added to the bacteria and incubated for 1 h at 37°C. 5-100 
μl of transformed bacteria were plated on agar-plates containing ampicillin (50 μg/ml) for 16 h at 37°C. 
2.2.2.8 Blue/White selection 
pGEM-T and pBluescript vectors contain a multiple cloning site flanked by the coding region of 
β-galactosidase. Insertion of DNA fragments within the multiple cloning site disrupts transcription of 
β-galactosidase after the induction by Isopropyl β-D-1-thiogalactopyranoside (IPTG). In the presence 
of 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal), it is thus possible to identify colonies 
 
1 http://www.thermoscientificbio.com/webtools/doubledigest/ 
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with religated (blue) versus recombinant (white) vectors. Ampicillin containing LB (lysogeny broth)-
agar plates were therefore coated with 200 µl IPTG/X-Gal solution prior to application of bacteria. 
Blue-white discrimination is best after 24 h at 4°C. 
2.2.3 Bisulfite sequencing 
In order to determine the methylation status of specific CpGs within regions of interest, sequencing of 
bisulfite converted DNA was conducted. This method is based on the consideration that 
5-methylcytosine is protected from bisulfite conversion; therefore, only unmethylated cytosine 
nucleotides are converted to uracil. Sequencing of bisulfite converted DNA and comparison with the 
reference sequence shows methylated cytosine remaining cytosine and unmethylated cytosine 
converted to thymidine. The workflow of the whole procedure is depicted in Figure 14. 
 
Figure 14: Workflow of the bisulfite sequencing procedure. 
Mouse brains were microdissected and areas of interest were punched (here PVN). Further, DNA and/or RNA were 
extracted from the micropunches. The DNA was bisulfite converted and the region of interest amplified by bisulfite specific 
PCR. PCR fragments were then l igated into pGEM-T vector for blue-white selection. White colonies were screened on an 
agarose gel for the correct insert s ite and subsequently sequenced by Sanger sequencing. Lastly, methylation pattern were 
determined (Bettscheider et a l. 2012). 
2.2.3.1 Bisulfite conversion 
For sodium bisulfite conversion of genomic DNA, 500 ng DNA extracted from tissue punches were 
converted using the EpiTect Bisulfite Kit (Qiagen) according to the manufactures instructions. 
2.2.3.2 Bisulfite specific PCR 
Bisulfite converted DNA was amplified using primers specific for bisulfite converted DNA  (Table 8). The 
amplification was conducted with HotStar Taq Polymerase (Qiagen) according to the manufactures 
instructions. Primer specific MgCl2 concentrations were evaluated prior to the experiment. 
Subsequently, successful amplification was verified by gel electrophoresis and the PCR product was 
purified using Nucleospin® Extract II Kit (Macherey-Nagel). 
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2.2.3.3 pGEM-T cloning 
Purified PCR products were ligated into the pGEM-T vector system (Promega) following the 
manufacturer’s instructions. The ligation reaction was purified by ethanol precipitation (2.2.2.5), 
transformed into DH5α bacteria (2.2.2.7) and plated on ampicillin containing LB-agar plates pre-coated 
with 200 µl IPTG/X-Gal solution (2.2.2.8) and incubated 16 h at 37°C. 
2.2.3.4 Colony PCR 
Recombinant, white colonies were picked with a sterile pipet tip and resuspended in 25 µl PCR reaction 
mixture containing 1x Taq buffer with (NH4)2SO4, 3.0 mM MgCl2, 0.6 mM dNTP, 0.4 µM Sp6 and T7 
Primers and 0.04 U/μl Taq DNA Polymerase final concentration. The reaction was incubated in a 
thermocycler with a program consisting of 5’/ 95°C + 10x (30’’/ 94°C + 30’’/ 56°C + 30’’/ 72°C) + 30x 
(30’’/ 94°C + 30’’/ 48°C + 30’’/ 72°C) + 5’/ 72°C. 5 µl of each PCR reaction were loaded on a 2% agarose 
gel to determine if the cloned inserts were of the correct size. For positive colonies, the remaining 
reaction was transferred to NucleoFast® 96 PCR Plates (Macherey Nagel). After 20 min 4000 rpm 
centrifugation at 4°C, 100 µl ddH2O were added to each well and again centrifuged 20 min 4000 rpm 
at 4°C. The DNA was recovered in 20 µl ddH2O on a shaker for 10 min. 2 µl of purified DNA was used 
directly for sequencing (2.2.3.5) or the plates were stored at -20°C. Sequences were analyzed using the 
BiQ Analyzer1 or QUMA2 . 
2.2.3.5 Sanger Sequencing 
100 ng purified PCR product or 300 ng Plasmid DNA were mixed in a total volume of 7.5 µl with 5 pmol 
Sequencing Primer (T7 or SP6) and sent for sequencing to the Biochemistry Core Facility at the MPI of 
Biochemistry, Martinsried, Germany. 
2.2.4 mRNA expression analysis 
2.2.4.1 Quantitative real time PCR (qPCR) 
RNA samples were reverse transcribed using RevertAid Premium Reverse Transcriptase with oligo(dT) 
primer according to the manufacturer’s instructions. The cDNA was analyzed in a Roche LightCycler 
using the LightCycler® FastStart DNA MasterPLUS SYBR Green I Kit. The relative expression levels were 
calculated using the ΔΔCT Method (Pfaffl 2001). The relative expression of the target gene was 
normalized against the housekeeping genes HPRT and MAS as reference while considering the PCR 
efficiencies. 
 
1 http://biq-analyzer.bioinf.mpi-sb.mpg.de/ 
2 http://quma.cdb.riken.jp 
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2.2.4.2 In-situ hybridization 
CRH transcripts were detected by riboprobes synthesized from pGem4zPST578 (Seasholtz et al. 1991) 
which contains a 578-bp PstI fragment (330-907bp from ATG) of the mouse CRH exon II. The plasmid 
was linearized with HindIII and in-situ probes radiolabeled with Uridine 5´-(α-thio) triphosphate [35S] 
were synthesized with SP6 Polymerase using the Riboprobe® Combination System-SP6/T7 RNA 
Polymerase kit. After template digestion with RQ1 DNAse (1 U/µg template DNA) for 15 min at 37°C, 
yeast tRNA (0.25 µg/ml) was added and the reaction was purified with RNeasy Mini Kit according to 
the manufacturer’s instructions. Lastly, 2 μl of DTT (5 M) were added to 100 μl eluate. Radioactive 
incorporation was measured using a liquid scintillation counter. Both, the labeled probes and the 2x 
hybridization buffer were denatured for 10 min at 80°C. The probes were then diluted to 
20 000 cpm/µl with hybridization buffer mixed 1:1 with deionized formamid containing 0.1% SDS, 0.1% 
sodium thiosulfate and 100 mM DTT. 25 µl of this solution were applied to each section, covered with 
coverslips and incubated overnight at 55°C in a humid chamber with 4x SSC/50% formamide. Before 
incubation, the slides were pretreated. First, the tissue was fixed for 5 min with 4% formaldehyde in 
PBS (phosphate-buffered saline) at room temperature followed by a two times rinse in PBS. Then, the 
slides were incubated for 10 min in freshly prepared 0.25% acetic anhydride in 0.1 M TEA/HCl. 
Afterwards, the slides were placed in a series of ethanol (70%, 1 min; 80%, 1 min; 95%, 2 min; 100%, 
1min), treated with chloroform for 5 min and again incubated in ethanol baths (100%, 1 min; 95%, 
1min) before air drying (Whitfield Jr et al. 1990). The next day, after the incubation with the probe, the 
coverslips were removed in 1x SSC and the slides underwent the following washing procedure. After 
two incubations in 1x SSC at room temperature for 20 min, the slides were incubated in 2x SCC/50% 
form-amide at 52°C for 30 min another 2 times. Incubation in 2x SSC for 10 min at room temperature 
was followed by RNAse (10 mg/ml in RNAse Buffer) treatment for 30 min at 37°C. Afterwards the slides 
were rinsed in room temperature 2x SSC and incubated for 30 min in 2x SSC at 52°C. After another 
rinse in room temperature 2x SSC the slides were incubated for 20 min in H2O at room temperature. 
Before drying, the slides were first dipped in 70% ethanol followed by 100% Ethanol. The slides were 
placed in a metal cassette and exposed to a BioMax film for 5-7 days. The autoradiography films were 
scanned and semiquantitative densiometric analysis was performed with ImageJ (Schneider et al. 
2012). 
2.2.5 Microdialysis 
All microdialysis experiments were performed within the Microdialysis Laboratory of the MPIP under 
the supervision of Dr. Anderzhanova as described before (Anderzhanova et al. 2013; Yen et al. 2015). 
In this experiment, 16 male C57BL/6 mice aged 2.5 month were single housed for at least one week 
prior to stereotactic surgery. At the day of surgery, animals were weight and premedicated with the 
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appropriate dose of the analgesic drug Metacam® (0.5 mg/kg body weight). During the surgery, 
animals were anesthetized with 2% isoflurane v/v in O2 at a flowrate of 1.2-1.4 NI/min and fixed in a 
stereotaxic apparatus. The microdialysis guide cannula was implanted into the right hippocampus at 
stereotactic coordinates AP -3.10, ML 3.00 DV-1.80 in accordance to the Mouse Brain Atlas (Paxinos 
and Franklin 2001). The guide cannula, two small (2 mm) custom-made stainless steel anchoring 
screws, and a metal peg were glued onto the bone surface and fixed with fast drying acrylic Pattern 
Resin LC. Animals were allowed one week of recovery with Metacam supplemented in the drinking 
water at 0.25mg/100ml for the first three days. After the surgery and during the experiment mice were 
housed in square Plexiglas chambers (16 cm×16 cm) on sawdust bedding. The day before the 
experiment, the microdialysis probe was inserted into the guide cannula under short (30-90 sec) 
isoflurane anesthesia. The perfusion lines consisting of FEP tubing were connected with the help of a 
dual channel liquid swivel to allow free movement of the animals and continuously perfused with 
sterile artificial cerebrospinal fluid at a flow rate of 0.3 μl/min. At the beginning of each experimental 
day, the flow rate was increased to 1.5µl/min and microdialysis fractions of 20 min each were collected 
in a refrigerated microsampler. After equilibration (80 min), four baseline fractions were collected 
followed by the intervention (stress or injection) , and then nine consecutive fractions (3 h) were 
collected. In order to minimize the number of animals, the experiment was designed to last three 
consecutive days and included a crossover of the pharmacological treatment procedure for each 
animal. On the first day, all animals were confronted with a physiological stressor, the elevated 
platform stress (Degroot et al. 2004). During the 5th collection period (each 20 min), the animals were 
placed on a small round-shaped platform with a diameter of 10 cm which was mounted on top of a 
vertical pole (40 cm) in the middle of a non-transparent white plastic box (45 cm×45 cm). The 
illumination at the level of the platform was 600-700 Lux. Within the microdialysis protocol, the 
elevated platform exposure was performed around 11 am during the light phase of a diurnal cycle. On 
the second and third day, all the animals were first injected with saline after the baseline period and 
subsequently (after 3 h) with either 1 mg/kg or 10 mg/kg corticosterone and another nine fractions 
were collected. Every day half of the animals were injected with either dose and the next day, the dose 
was opposite. At the end of each experimental day, the flow rate was reduced to 0.3µl/min overnight. 
Each run consisted of a batch of four animals that were analyzed in parallel. In the first batch, the 
physiological stress also included a tail vein cut for blood collection before and after the elevated 
platform, which was omitted in the consecutive batches due to technical difficulties. 
2.2.6 Corticosterone radioimmunoassay (RIA) 
Corticosterone RIA, either from DRG Diagnostics or MP Biomedicals, were performed according to the 
manufacturers’ protocol with minor adjustments. The samples (plasma, serum or artificial CSF) were 
diluted in Steroid-Diluent in respect to the expected corticosterone concentration depending on the 
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experiment. Further, the samples were processed according to the manufacturer’s protocol with 
halved volumes. For microdialysis’ artificial CSF, 25 µl sample were diluted 1:2 with 25 µl Steroid-
Diluent. Blood samples were diluted 1:200 (5 µl in 1 ml), 1:100 (10 µl in 1 ml) or 1:50 (10 µl in 500 µl) 
depending on the experiment.  
2.2.7 TruSeq® Targeted RNA sequencing 
For the assessment of gene expression from several genes in a huge number of samples, TruSeq® 
Targeted RNA sequencing was chosen. This method allows the parallel processing of 12-1000 genes in 
48-384 different samples in a single sequencing run on the MiSeq Sequencer (Illumina).  
In order to avoid batch effects, we took care to assign samples randomly distributed during RNA 
extraction and library preparation. We used 8 samples per group from our 4 experimental groups and 
12 brain regions examined which summed up to a total number of 384 samples. During RNA-extraction, 
24 samples were extracted at once, whereas the library preparation was done in four 96-well plates. 
Each 96-well plate contained 3 brain regions which were distributed randomly into the columns of the 
plate. Each plate column contained 2 samples each from the 4 experimental groups randomly 
distributed over the rows. 3 columns of a 96-well plate were assigned to one RNA-extraction from each 
of the 3 brain regions on that plate. 
 
Figure 15: Workflow of the TruSeq® Targeted RNA sequencing library preparation protocol. 
Firs t, the total RNA is reverse transcribed into cDNA. The specific primers for the transcripts of 
interest are then hybridized to the cDNA and connected by the extension-ligation step. Through 
the addition of the indexing primers the samples are marked , amplified and finally pooled to make 
up the sequencing library. ULSO: Upstream Locus-Specific Oligo, smRNA: small RNA sequencing 
primer binding site, DLSO: Downstream Locus-Specific Oligo, SBS3: Read 2 sequencing primer 
binding s ite; P7: Flow cell binding site, P5: Flow cell binding site (Illumina). 
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The library preparation was conducted according to the manufacturer’s protocol, which is summarized 
in Figure 15. Briefly, at first, specific assays for the genes of interest have to be chosen in the 
DesignStudio1. The specific primers for these assays are combined and produced by Illumina and result 
in a targeted oligo pool (TOP). This TOP is applied to the reverse transcribed RNA whereby 50 bp long 
sequences of the specific genes are amplified. Through the application of two indexing primers, 
samples are marked, which allows all samples to be combined in one library and sequenced at once.  
For the blood samples, a separate library preparation was performed. Thereby the specific properties 
of the blood RNA samples could be taken into account. The protocol for degraded samples with an 
initial amount of 200 ng RNA was used. These adjustments and separate library preparation of blood 
samples in respect to brain samples provided improved sequencing results.  
After sequencing with the MiSeq Sequencer, all FastQ files were analyzed with FastQC (Andrews 2010) 
and reads with Phred Scores lower than 20 or a length smaller than 25 bp were filtered out with 
PRINSEQ (PReprocessing and INformation of SEQuence data) lite Version 0.20.4 (Schmieder and 
Edwards 2011). Subsequently, the reads were aligned with Burrows-Wheeler Aligner (BWA) Version 
0.7.12 (Li and Durbin 2009) with the manifest file provided by Illumina as reference. The number of 
reads per gene were summed up in every sample and reads from multiple runs were summed together. 
2.2.8 GeneMANIA network analysis 
GeneMANIA is an online tool available at http://www.genemania.org. It integrates a vast variety of 
genomic and proteomic data from GEO, BioGRID, Pathway Commons and I2D as well as well as 
organism-specific functional genomics data sets from nine different species including human and 
mouse (Warde-Farley et al. 2010). Co-expression of human genes has been evaluated by selecting all 
co-expression data sets without the addition of related genes or attributes.  
2.2.9 Statistical analysis of CRH data  
The statistical analysis of CRH expression data and corticosterone levels in maternal separated females 
was conducted with SigmaPlot 12.5. Data were analyzed by two-way ANOVA with post-hoc Tukey test. 
Significant differences are marked with stars: * p<0.05; ** p<0.01; *** p<0.001. All data are plotted as 
mean±SEM (standard error of mean). 
2.2.10 Statistical analysis in R  
The statistical analysis of the sequencing data was done in R version 3.2.3 (2015-12-10) (R Core Team 
2016) following an in-house pipeline including several different packages: 
Bioconductor packages: Rgraphviz (Hansen et al.), DESeq2 (Love et al. 2014), SVA (Leek et al. 2016), 
limma (Ritchie et al. 2015). 
 
1 http://designstudio.il lumina.com/ 
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CRAN packages: pheatmap (Kolde 2015), RColorBrewer (Neuwirth 2014), ggplot2 (Wickham and Chang 
2016), MASS (Ripley et al. 2016) GeneNet (Schaefer et al. 2015), iGraph (Csardi and Nepusz 2006), 
NetIndices (Soetaert et al. 2014), colorspace (Ihaka et al. 2015), corrplot (Wei and Simko 2016), 
gtools (Warnes et al. 2015), calibrate (Graffelman 2013) 
2.2.10.1 Normalization, outlier detection and batch correction of the data 
Filtering genes: Before the analysis, the 10% lowest expressed genes over all samples were excluded. 
Thereby, genes that were very low or not expressed were removed. 
Normalization: DESeq2 was used to normalize the raw counts.  
Filtering outliers: Variance stabilizing transformation and rlog transformation were applied to the data 
and clustered by similarity in heatmaps. Additionally, the similarity of the samples was visualized in a 
multi-dimensional scaling (MDS) plot. Samples that clustered separately in the heatmap as well as the 
MDS plot were excluded as outliers. 
Batch correction: The DESeq normalized data was examined by principal component analysis (PCA). 
Technical batch effects such as RNA extraction or library preparation plate and biological effects like 
treatment group were inspected by coloring the samples accordingly in the plots. To correct for batch 
effects, surrogate variable analysis (SVA) from the R/Bioconductor package sva was applied. The sva 
package includes the specific function svaseq() for the use with count data (Leek 2014). Significant 
surrogate variables were calculated according to Leek and Storey (2007). The model matrix of the full 
model included the experimental groups (adult and early life treatment) and was compared to the null 
model containing all the other adjustment variables (e.g. RNA extraction, preparation plate). In the 
next step, the significant surrogate variables were associated to all sample properties in a correlation 
matrix. The residuals after applying the sva variables were again examined in PCA plots. If there were 
still samples detected that were more than four standard deviations away from the mean in either of 
the first two principal components, the samples were excluded.  
2.2.10.2 Differential expression analysis 
For differential expression analysis, first, a generalized linear model with negative binomial distribution 
(function glm.nb() of package MASS) was used since count data is generally expected to be negative 
binomial distributed. In our case however, the data for some genes was not following a negative 
binomial distribution. Therefore, we tested for non-normal distribution with a Shapiro-Wilk test first 
and given this was not significant (p ≥ 0.05) we tested for differential expression with a linear model 
(function lm() ). To note, in the Shapiro-Wilk test the null hypothesis is normal distribution, thus it 
has not to be significant to allow tests that assume the data to be normally distributed. If a non-normal 
distribution was detected, the generalized linear model with negative binomial distribution was used 
and afterwards tested for its goodness of fit. All reported p-values were calculated either by the linear 
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model with normally distributed data or by the generalized linear model with negative binomial 
distribution that passed the goodness of fit test. In all tests, the normalized data was used and the 
model formula included the surrogate variables as covariates. The interaction effect as well as the 
specific treatments (early life, adult) were tested separately with the alternative treatment as 
additional covariate. Significance is reported after controlling for multiple testing with a false discovery 
rate (FDR) lower than 10% (q-value< 0.1) 
Differentially expressed genes were visualized in volcano plots using gtools and calibrate. 
2.2.10.3 Network analysis 
Networks were built with GeneNet and visualized with Rgraphviz. From the normalized and batch 
corrected gene expression residuals a partial correlation matrix was built. The networks were then 
built from the significant edges (qval ≤ 0.2) for every condition in each of the brain regions. The network 
properties were analyzed using iGraph and visualized in pheatmaps.  
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3 Results – Epigenetic regulation of CRH in the PVN 
No differential CRH expression in adult male mice with a history of maternal separation had been 
detected in our previous experiments. However, initial experiments with female mice analyzed with 
respect to the specific stage of their estrous cycle (2.2.1.2) were promising.  
3.1 Corticosterone Measurements 
Corticosterone levels of female mice exposed to maternal separation were measured at the time of 
sacrifice (Figure 16).  
 
Figure 16: Corticosterone levels of 3-month-old maternal 
separated female mice. 
Corticosterone levels were measured in plasma collected from 
trunk blood during sacrifice The ANOVA showed a significant 
interaction effect (F=4.778, p=0.032). Al l va lues are mean±SEM, 
Co: Control ; E: Estrus; MS: maternal separated; D: Diestrus. * 
p<0.05; ** p<0.01. (Experiments conducted in collaboration with 
Florian Raabe) 
The corticosterone levels of control mice were significantly different between mice in estrus and 
diestrus. This suggests a reciprocal link between estrogen levels, which are higher in estrus, and the 
secretion of corticosterone. This difference in corticosterone levels was not detected in females after 
maternal separation suggesting that estrogen levels and HPA axis activity were disconnected. 
3.2 CRH mRNA expression 
The mRNA expression of CRH, one of the main stress hormones of the HPA axis, was measured in the 
PVN where it is highly expressed. 
** 
* 
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3.2.1 CRH mRNA expression at 3 months 
Female mice with a history of maternal separation were sacrificed after 3 months. At this time-point, 
mice are well in their adulthood. In-situ hybridization for CRH in the PVN revealed an estrous cycle 
dependent expression of CRH in control mice (Figure 17). 
 
Figure 17: In-situ hybridization for CRH expression in the PVN of 
3-month-old maternal separated female mice. 
The ANOVA showed a  significant effect of early l ife stress 
(F=5.071, p=0.032) and interaction effect (F=8.494, p=0.007). All 
va lues are mean±SEM, Co: Control; E: Estrus; MS: maternal 
separated; D: Diestrus. ** p<0.01; *** p<0.001. (Experiments 
conducted in collaboration with Florian Raabe) 
Similar to the corticosterone levels, differences in CRH expression between estrous cycle phases was 
not present in maternal separated females. A highly significant difference between control and 
maternal separated mice in the diestrus phase was detected. This suggests that, at the level of the 
PVN, CRH expression is uncoupled from estrogen levels in maternal separated mice. 
3.2.2 CRH mRNA expression at 1 year 
In another cohort, maternal separated female mice were 1-year-old; an age that is usually not reached 
in wild life and can only be achieved in captivity.  
Due to the limited availability of material, CRH expression was assessed in these mice using qPCR. At 
this time-point, no differences in CRH expression were identified between the different groups (Figure 
18). This partly resulted from the high variability of the measurements and possibly from dilution 
effects. 
** 
*** 
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Figure 18: qPCR for CRH expression in the PVN of 1-year-old 
maternal separated female mice. 
Relative expression compared to control diestrus is plotted. All values 
are mean±SEM, Co: Control; E: Estrus; MS: maternal separated; D: 
Diestrus  
3.3 CRH promoter methylation 
CRH expression differences could occur due to different reasons. Differences in synaptic plasticity 
could result in altered transcription factor modifications or differences in the expression of 
transcription factors themselves. Furthermore, innervations from connected brain regions could be 
changed or neurons could undergo morphological changes. Nevertheless, we wanted to focus herein 
on the previously investigated mechanism, the long-term propagation of early life experiences by CpG 
methylation. Differential methylation could affect the expression of a gene in various ways. The binding 
of transcription factors or structural proteins could be altered and affect the composition of the 
transcription initiation complex. The body of the CRH gene is covered by a large CpG Island which is 
very sparsely methylated (Appendix 8.1, Raabe 2016). Therefore, we concentrated on the 10 CpG sites 
preceding the transcription start site. 
3.3.1 CRH promoter methylation at 3 months 
First, we investigated the CRH promoter CpG methylation at 3 months, the time-point where CRH 
expression as well as corticosterone levels were uncoupled from estrogen cycling in maternal 
separated mice. No significant differences were detected in either of the CpGs (Figure 19). In addition, 
no methylation differences were present between estrous cycle stages in both MS and control mice. 
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Figure 19: CpG methylation of the CRH promoter region in the first cohort of maternal 
separated female mice at 3 months. 
Co: Control , n=12; MS: maternal separated, n=11. 
This result was reproduced in a second cohort of animals (Figure 20).  
 
Figure 20: CpG methylation of the CRH promoter region in the second cohort of maternal 
separated female mice at 3 months. 
Co: Control , n=4; MS: maternal separated, n=4 
3.3.2 CRH promoter methylation at 1 year 
After 1 year, again no differences in CpG methylation at the CRH promoter were detected. Moreover, 
the methylation pattern resembled the pattern at 3 months without any age dependent changes in 
DNA methylation (Figure 21).  
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Figure 21: CpG methylation of the CRH promoter region of maternal separated female 
mice at 1 year. 
Co: Control , n=12; MS: maternal separated, n=10 
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4 Results – GR-response eQTLs associated with MDD and SCZ 
In the second part, human GR-response eQTL genes previously identified by Arloth et al. (1.10) were 
studied in two mouse models of early life stress. In the current study, not only MDD-associated eQTL 
genes but also GR-response eQTLs which matched nominally significant hits in the latest GWAS for 
schizophrenia (Schizophrenia Working Group of the Psychiatric Genomics Consortium 2014) were 
investigated. These disease-related eQTL genes are listed in Appendix 8.2 and form a tightly connected 
co-expression network as determined from publicly available data obtained through GeneMANIA 
(Figure 22). 
 
Figure 22: Human GeneMANIA co-expression network. 
The MDD/SCZ-related GR-response eQTL genes form a  tightly interconnected co-expression network. Edges represent 
co-expression as determined by GeneMANIA from the literature database.  
Results 
42 
4.1 TruSeq® sequencing vs microarray expression  
Using a new method, TruSeq® Targeted RNA sequencing (2.2.7), we first had to validate its reliability. 
Therefore, we compared the expression of our genes of interest in three exemplary brain regions from 
mice sacrificed three hours after dexamethasone (10 mg/kg) injection between TruSeq® sequencing 
and microarray analysis. Table 10 shows that the expression of the analyzed genes correlates strongly 
between both techniques. 
Table 10: Correlation between TruSeq® sequencing and microarray expression 
 Amygdala dCA3 Pituitary 
Correlation all genes 0.75 0.77 0.56 
Correlation FC > ±1.1 0.93 0.94 0.81 
After filtering out noisy genes with a fold change lower than ±1.1, the correlation becomes even 
stronger. This illustrates that TruSeq® sequencing produces results comparable to microarrays.  
4.2 Microdialysis 
In order to assess the kinetics of corticosterone levels in the mouse brain after a single intraperitoneal 
(IP) injection of corticosterone, we conducted a microdialysis experiment. We aimed at identifying a 
concentration of corticosterone that best corresponds to a physiological stressor. As exemplary target 
region, the hippocampus was used. Two doses of corticosterone, 1 mg/kg and 10 mg/kg, were tested 
and compared to the stress response induced by the elevated platform (2.2.5).  
Following treatment (time-point 0), corticosterone levels were increased in all conditions (Figure 23). 
Only a slight but still detectable increase was observed after injection with saline, as expected. 
Exposure to the elevated platform resulted only in a mild increase of corticosterone. The combination 
with a tail vain cut, however, markedly increased the measured corticosterone levels, which peaked in 
this case at 40 min after the intervention. Corticosterone injection, on the other hand, resulted in an 
immediate increase, which plateaued between 20 and 40 minutes. After injection of 10 mg/kg 
corticosterone, levels in the microdialysate increased strongly and reached more than five times the 
level of the physiological stress response. Moreover, corticosterone levels stayed very high for an 
extended time period, just returning to the physiological peak level after three hours. After injection 
of 1 mg/kg corticosterone, levels peaked at around 1.5 times of the elevated platform stress combined 
with a tail vain cut. Here, the time necessary to reach baseline was similar in both conditions.  
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Figure 23: Corticosternme levels in microdialysis fractions from mice hippocampus after exposure to a physiological 
stressor and compared to corticosterone injection. 
Arti ficial cerebrospinal fluid was collected in fractions of 20 minutes. Four fractions were collected before the treatment 
(time-point 0) and collections continued until 3 hours after the treatment. Experimental groups: Cort: Corticosterone 
injection with the respective dose; EP Stress + cut: Elevated platform stress with tail va in cut for blood collection; EP Stress: 
Elevated platform stress; Saline: Saline injection. 
This experiment highlights that the determination of the bioavailability of pharmacological substances 
in the tissue of interest is crucial after systemic injections to best mimic physiological conditions. Given 
the results of this experiment, we concluded that a dose of 1 mg/kg best corresponds to a strong 
physiological stressor. Therefore, this dose was used in the following experiments. 
4.3 Maternal separation and corticosterone injection 
4.3.1 Animal cohort of maternal separated mice 
In the first mouse model, we used male C57BL/6 mice with a history of early life stress due to maternal 
separation. These mice received a corticosterone injection in adulthood (Figure 24). Maternal 
separation (MS) was conducted 3 hours daily for the first 10 days of life in the MS groups. At the age 
of 3 months, the mice were sacrificed either without further treatment (naïve) or following an 
intraperitoneal injection of 1 mg/kg corticosterone 3 hours before sacrifice. 
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Figure 24: Maternal separation mouse model. 
Time-pregnant mothers were assigned to maternal separation (MS) or control groups. The pups of 
mothers in the MS group were transferred to a  new ca ge for 3 hours per day during the fi rst 10 
days . When the mice were aged 3 months, they either received a 1 mg/kg corticosterone injection 
or were left undisturbed before sacrifice. The blood and brains of all animals were collected. 
In total, this resulted in four groups: a control group which did not receive any treatment (Co-naïve); a 
group which only experienced maternal separation but no adult corticosterone injection (MS-naïve); a 
group which received only an acute corticosterone injection 3 hours before sacrifice in adulthood (Co-
inject); and a group which experienced both, maternal separation and corticosterone injection (MS-
inject). From all mice, brains and pituitaries were collected. Additionally, trunk blood for RNA 
extraction as well as separate blood samples for corticosterone measurements were obtained. 
4.3.1.1 Basal corticosterone levels at 5 weeks 
To validate the maternal separation procedure, we conducted tail vein bleedings in the 5-week-old 
mice and assessed the basal corticosterone levels. We could not detect any differences between the 
corticosterone levels of maternal separated and control mice at this time-point (Figure 25). 
 
Figure 25: Basal corticosterone levels from 5-week-old 
maternal separated mice. 
Corticosterone levels were measured in serum extracted 
from ta i l vein blood collected in the afternoon. All va lues are 
mean±SEM, Co: Control; MS: maternal separated 
4.3.1.2 Basal corticosterone levels at 3 month  
Corticosterone levels were assed in the trunk blood of all mice after sacrifice at 3 months (Figure 26).  
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Figure 26: Basal corticosterone levels of 3-month-old 
maternal separated mice. 
Corticosterone levels were measured in serum extracted 
from trunk blood collected at sacrifice. All values are 
mean±SEM, Co: Control; MS: maternal separated; Naïve: no 
adult treatment; Corticosterone: 1 mg/kg corticosterone 
injection 3 hours prior to sacrifice. 
No significant differences between control and MS mice were detected, which is in accord with 
previous experiments. Interestingly, there were no differences in corticosterone levels between 
corticosterone injected and naïve mice present. This suggests that the levels of corticosterone in the 
blood already normalized 3 hours after the injection. 
4.3.2 GR-response MDD and SCZ related eQTL gene expression 
The gene expression of the mouse orthologues of GR-response MDD- and SCZ-related eQTL genes (8.2) 
was investigated in 12 different brain regions including amygdala (AMY), bed nucleus of the stria 
terminalis (BNST), cerebellum (CER), dorsal hippocampal Cornu Ammonis (CA) 1 region (dCA1), dorsal 
hippocampal CA3 region (dCA3), dorsal dentate gyrus (dDG), prefrontal cortex (PFC), pituitary (Pit), 
paraventricular nucleus (PVN), ventral hippocampal CA1 region (vCA1), ventral hippocampal CA3 
region (vCA3) and ventral dentate gyrus (vDG). These brain regions were selected for their contribution 
to the regulation of the stress response as well as their role as targets of the stress response. The 
cerebellum was assessed as negative control, where no stress related expression differences were 
expected. Additionally, we also investigated the expression of these genes in the blood. This opens the 
opportunity to directly relate the results to the human analysis. 
4.3.2.1 TruSeq Sequencing 
The pooled TruSeq library containing 384 brain samples as well as the library for the blood samples 
were loaded on the Illumina MiSeq sequencer. Table 11 lists the amounts loaded and yield of the 
specific sequencing runs. For the brain samples, three sequencing runs were performed in order to 
increase the coverage of single transcripts over all samples. For blood, a second run had to be 
performed due to the low amount of the clusters passing filter (PF) in the first run. In the second run, 
the amount of library loaded was halved and thereby nearly 90% clusters PF could be achieved.  
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Table 11: Quality parameters of sequencing runs from maternal separated mice. 
 Load 
Cluster density 
(K/mm2) 
Clusters 
PF (%) 
Total reads 
Reads past 
filter 
% reads 
identified 
Brain 1 10 pM 1234 68.6 27,616,172 19,561,760 75.86 
Brain 2 8 pM 1208 85.6 27,616,220 23,639,608 81.64 
Brain 3 8 pM 1048 90.0 25,587,506 23,077,160 83.38 
Blood 1 8 pM 1110 35.1 26,117,084 9,214,041 81.09 
Blood 2 4 pM 953 89.4 23,932,584 21,401,722 82.94 
Generally, the determination of the appropriate amount of sequencing library to be loaded on the 
MiSeq instrument can be demanding. The protocol suggests 10-15 pM of library to be loaded. 
However, as depicted in Table 11, much lower quantities are sometimes necessary to receive good 
results. The actual amount of library depends heavily on the quantification step, typically performed 
with the Agilent 2100 Bioanalyzer. From our experience, the Bioanalyzer rather underestimates actual 
sample concentrations. Therefore, it can be helpful to additionally use a second method of 
quantification, e.g. the Qubit®, to determine the right concentration. 
4.3.2.2 Quality control and data assessment 
The analysis of heatmaps from rlog and variance stabilizing transformed data as well as MDS plots 
allowed us the identification of five outlier samples: 109_PVN, 95_PVN, 243_BNST, 229_vDG, 83_vDG 
(AnimalNr_BrainRegion). Figure 27 presents two principal component (PC) plots of the normalized data 
after the exclusion of these samples.  
 
Figure 27: Principal component (PC) plots of normalized count data from maternal separated mice. 
In the left plot, the samples are colored by bra in region; in the right plot, the samples are colored by l ibrary preparation 
plate. 
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In the PC plot colored by library preparation plate, a batch caused by this factor was detected. Samples 
of plate 1 and 4 are mostly overlaying but samples from plate 2 and 3 separate from the other plates. 
A subset of samples from plate 2 clusters away from all the other samples. We examined the properties 
of these samples but could not assign the separation to any of our suspected batch effects. The 
separated samples belong to four specific plate columns which are not adjacent to each other but 
rather randomly distributed on the plate. Moreover, these samples do not belong to a specific brain 
region as depicted in the PC plot colored by brain region. 
To overcome the problem of hidden batch effects, surrogate variable analysis (SVA) was applied. Four 
significant surrogate variables (SVs) were determined and their correlation with the sample properties 
is depicted in Figure 28. The highest correlation of the SVs was present with RNA extraction and library 
preparation plate, but also plate column and brain region correlated significantly. SV2 and SV4 showed 
only minor correlations with the suspected batch effects. This illustrates that the SVA also corrects for 
unknown batch effects in the sample. 
 
Figure 28: Correlation matrix of surrogate variables (SVs) with 
sample properties. 
Fi l led colored boxes mark significant associations; positive and 
negative correlations are marked blue and red respectively. 
After the SVA, the corrected dataset has been assessed again by PCA. Two samples, 267_PFC and 
81_BNST, had to be excluded due to more than four standard deviations distance from the mean of all 
samples. The PC plots of the final dataset are presented in Figure 29. The samples from the different 
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library preparation plates are now much closer together and all samples from plate 2 cluster together. 
Plate 2 and 3 still cluster rather separately but they overlay much better with plate 1 and 4 compared 
to the raw data.  
 
Figure 29: Principal component (PC) plot after batch correction of count data from maternal separated mice. 
In the left plot, the samples are colored by the brain region; in the right plot, the samples are colored by the library 
preparation plate. 
Overall, this data demonstrates that batch correction is necessary and SVA is suitable to use for this 
kind of data. The data shown here are only the brain samples, the blood samples have been processed 
separately in the same way (Appendix 8.3). 
4.3.2.3 Differential expression of GR-response MDD- and SCZ-related eQTL genes in the 
brain 
Differential expression analysis in the investigated brain regions of the maternal separated mice 
revealed only a few significantly different genes after multiple testing correction (Table 12).  
Table 12: Differentially expressed genes in brain tissues of 
maternal separated mice 
 ELS Corticosterone Interaction 
AMY       
BNST       
CER       
dCA1       
dCA3       
dDG       
PFC     Cct7 
Pit   Pitpnm2   
PVN Zfp641 Timm23   
vCA1       
vCA3       
vDG   Abhd5 Zfp641 
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Acute corticosterone injection had the strongest effect with the regulated genes present in the classic 
target regions, PVN, pituitary and dentate gyrus. An interaction effect was also detected in the 
prefrontal cortex. 
4.3.2.4 Differential expression of GR-response MDD- and SCZ-related eQTL genes in blood  
In the blood, nine genes were significantly regulated after acute corticosterone injection in adulthood 
(Figure 30). Three genes (Rps25, Spag9, and Impdh2) were down regulated and six genes (Rbm4, Lcn2, 
Hmbs, Abdh5, Ociad2 and Fth1) were upregulated. 
 
Figure 30: Differentially expressed genes in blood for the effect of acute corticosterone injection 
in adulthood. 
Green dots mark genes which are up- or down-regulated more than 1.15 fold and surpassed the 
multiple testing threshold (q-value <0.1). The names of the genes are noted beside the dots. 
Orange dots mark genes that are up- or down-regulated more than 1.15 fold but did not surpass 
the multiple testing threshold. Black dots mark genes that were not regulated. 
There were neither any genes significantly regulated by early life stress nor an interaction effect 
present in blood.  
4.3.3 Network analysis 
Network analysis of all brain regions, including blood, revealed region specific co-expression networks 
in most of the brain regions (Figure 31). In blood, strong networks are present in all experimental 
groups. Brain regions that present strong network connectivity include vCA3, dCA3, dDG, pituitary, 
and, interestingly, cerebellum. The network in the control-injected group of the cerebellum is one of 
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the biggest. This highlights that even though the cerebellum is no classical stress regulatory region, a 
pharmacological corticosterone stimulus activates this brain region. This is in l ine with the distribution 
of the glucocorticoid receptor, which is highly expressed in the cerebral cortex (Morimoto et al. 1996). 
GR activation in the cerebellum could be important for regulating apoptosis in neuronal progenitors 
(Noguchi et al. 2008) but the adult function still has to be investigated. 
 
Figure 31: Network properties of co-expression partial correlation networks from maternal separated mice. 
Depicted are the total number of edges and nodes in the specific networks as well as the absolute sum of the partial 
correlation coefficient (pcor) and the link density in the respective networks. 
In Figure 32, the genes that are part of the specific networks are depicted in a heatmap. The clustering 
reveals neither clear region specificity nor clustering by experimental conditions. The strongest 
networks, “CER Co inject”, “DG Co naïve” and “Blood Co naïve” cluster apart from each other as well 
as the other regions. The four different conditions in blood, which all show substantial network 
connectivity, do not cluster together as well.  
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Figure 32: Network node genes and edges per brain region and condition. 
On the top, the regions and experimental conditions are color coded and clusterd. On the left s ide of the matrix, the node 
genes are presented with the cluster diagram on the right. The colors in the matrix depict the amout of edges established 
from each gene in the specific networks. 
4.4 Limited nesting material and chronic social defeat stress 
In the second mouse model, we investigated the interaction between limited nesting material early in 
life and chronic social defeat stress in adulthood on the expression of the GR-response MDD- and SCZ-
related eQTL genes. 
4.4.1 Animal cohort 
The animal experiments of this cohort were conducted by Sara Santarelli and the group of Mathias 
Schmidt in Balb/c mice (Santarelli 2015). The experimental timeline and the study groups are 
summarized in Figure 33. In this experiment, two opposing manipulations were conducted early in life 
as well as in adulthood. First, early handling (EH), which increases maternal care (Liu et al. 1997; Caldji 
et al. 1998), in contrast to the limited nesting and bedding material paradigm (LM), which was shown 
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to induce fragmented maternal care (Rice et al. 2008), was used. Later, in adulthood, mice received 
either chronic social defeat stress (CD), a paradigm which has been extensively used and validated 
within and outside the institute (Berton et al. 2006; Kinsey et al. 2007; Haenisch et al. 2009; Wagner 
et al. 2011; Balsevich et al. 2014) or were housed together with an ovariectomized female mice (OX) 
as positive social stimulus. Animals either experienced positive or negative conditions in both early life 
and adulthood (EHOX or LMCD respectively) or experienced opposing conditions in early life and 
adulthood (EHCD and LMOX). Amygdala, BNST, cerebellum, dCA1, dCA3, dDG, PFC, PVN, vCA1, vCA3, 
and vDG were collected from frozen brains of these animals. Since there were no pituitaries available 
from these animals, the nucleus accumbens (Nac) was collected additionally. 
 
Figure 33: Experimental timeline and conditions of limited nesting material and chronic social defeat stress mice. 
Between postnatal day (PND) 2 and 9 the litters were randomly exposed to either early handling (EH) or limited nesting 
material (LM) conditions. Subsequently, they were returned to s tandard housing conditions until weaning (PND 28) where 
they were group housed until PND 67. Animals were then randomly assigned to either chronic social defeat stress (CD) or 
housed with an ovariectomized female (OX) for 21 days. Afterwards behavioral testing was conducted and all animals were 
sacrificed at PND 100 (addapted from Santarelli 2015). 
4.4.2 Library preparation and sequencing 
The expression level of the GR-response MDD- and SCZ-related eQTL genes was measured by TruSeq® 
Targeted RNA sequencing. As before, four sequencing plates with a total of 384 samples were prepared 
and the pooled library loaded on the MiSeq sequencer (Table 13). 
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Table 13: Quality parameters of sequencing runs from LMCD mice 
 Load 
Cluster density 
(K/mm2) 
Clusters 
PF(%) 
Total reads 
Reads past 
filter 
% reads 
identified 
Run 1 10 pM 1139 88.84 26.116.940 23.202.998 85.4637 
Run 2 10 pM 1126 91.13 26.625.978 24.274.608 86.0245 
Run 3 10 pM 1119 88.19 25.438.136 22.434.052 85.0683 
Run 4 10 pM 1026 90.12 24.029.084 21.657.320 84.3328 
In this experiment, three sequencing runs with all the samples had good yields. However, the index 
read distribution (Figure 34) was broad in this experiment resulting in some samples being more than 
100-times less present in the library than others. Therefore, the lowest 30% of all samples, which were 
below 0.15% of all index reads identified, were pooled together separately. These samples were than 
sequenced in a 4th MiSeq sequencing run.  
 
Figure 34: Index read distribution of the first sequensing run. 
The percentage of identified reads per index number (sample) is plotted. The lowest 30% of 
samples have below 0.15% identified reads.  
Overall, the sequencing of these libraries was successful with a yield of ~20 million identified reads per 
run.  
4.4.3 Quality control and data assessment 
The principle component plots of the normalized raw data illustrate a clustering by brain region (Figure 
35). The effect of brain region is stronger compared to the effect of library preparation plate. This is 
best visible for plates 3 and 4, which both separate into two clusters that correspond to specific brain 
regions. Otherwise, plate 2, 3, and 4 overlap with each other while plate 1 clusters more separately in 
the middle between the different regions of plate 3 and 4.  
30% 
0.15% 
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Figure 35: Principal component (PC) plot of normalized count data of LMCD mice. 
In the left plot, the samples are colored by the brain region; in the right, plot the samples are colored by the library 
preparation plate. 
Even though a strong brain region effect is present, we decided not to protect this effect in the SVA for 
several reasons. First, three brain regions always correspond to one library preparation plate. Due to 
this design, protecting for the brain region effect would make a correction concerning the plate effect 
not reliable. The plate effect could not be distinguished from the brain region effect by the SVA 
anymore. Moreover, a comparison between brain regions is only possible after correcting for the brain 
region effect. In the end, even though we corrected for the brain region effect, the brain regions still 
cluster together in the principal component plot after the batch correction (Figure 37). 
In this experiment, the surrogate variables are highly and significantly correlated only with the 
suspected batch effects (Figure 36). On the other hand, the experimental conditions, which were 
protected from the correction, are not correlated with the surrogate variables. Interestingly, SV5 does 
not correlate with any of the observed parameters. This suggests a hidden batch effect, which the SVA 
is correcting. 
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Figure 36: Correlation matrix of surrogate variables (SVs) with 
sample properties. 
Fi l led colored boxes mark significant associations; positive and 
negative correlations are marked blue and red respectively. 
 
 
Figure 37: Principal component (PC) plot after batch correction of count data from LMCD mice. 
In the left plot, the samples are colored by the brain region; in the right plot, the samples are colored by the library 
preparation plate. 
The SVA corrected data is presented in Figure 37. Two outliers (83_dCA1 and 97_vDG) were excluded 
due to more than four standard deviations distance from the mean of all samples. The principal 
component plots illustrate the disappearance of previously detected clusters, especially the different 
plates are merged together. 
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4.4.4 Differential expression of eQTL genes 
Similar to the previous experiment, differential expression analysis could not detect many significantly 
regulated genes. The acute stress in adulthood again resulted in the highest number of differentially 
expressed genes, in this experiment together with the interaction effect (Table 14). 
Table 14: Differentially expressed genes in LMCD mice 
 ELS Adult Interaction 
AMY     Higd1a 
BNST       
CER       
dCA1   Fth Ccndbp1 
dCA3       
dDG   Hist1h2al Rps12 
PFC       
Nac Snrnp70 AW209491 Abhd5 
PVN       
vCA1   Abhd5   
vCA3       
vDG       
 
4.4.5 Network analysis 
The network analysis of partial correlation co-expression networks revealed strong networks in the 
PVN as well as the dorsal and ventral CA1 (Figure 38). Other brain regions like the PFC, AMY and BNST, 
but also other hippocampal subregions, showed only sparse network connectivity. In this experiment, 
no networks were present in the cerebellum. This suggest that the physiological stress used in this 
experiment did not activate the GR-response genes in the cerebellum, in contrast to the previous 
experiment. This would be in line with the concept of different stressful stimuli triggering specific 
physiological systems. Thus, beside an increase in corticosterone, the context of the stressful situation 
is critical (Koolhaas et al. 2011). 
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Figure 38: Network properties of co-expression partial correlation networks from LMCD mice. 
Depicted are the total number of edges and nodes in the specific networks as well as the absolute sum of the partial 
correlation coefficient (pcor) and the link density in the respective networks. 
The network node genes of the specific networks in the three most connected regions are depicted in 
Figure 39 and clustered by the number of edges and the betweenness of the genes. The two most 
connected networks are observed in the early handling groups of the PVN and these cluster together 
in terms of their edges and genes involved. Notable, the betweenness of the genes is different over all 
of these highly connected networks, which highlights their structural differences.  
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Figure 39: Number of edges and betweenness of network node genes in the most connected regions, PVN, dCA1 and 
vCA1. 
Node genes are clustered by the number of connecting edges (A) or their betweenness (B) in the specific networks. 
Specifically in the PVN, the EHOX and EHCD networks have the most node genes and these are 
connected by the most edges compared to all other networks. Nevertheless, the two networks are 
very different. Figure 40 presents the network graph of all four experimental groups. The structural 
differences between the two early handling networks become clearer when focusing on specific genes. 
One example is the Pds5a gene. It is present in the networks of both groups with a substantial amount 
of edges but only shows a high betweenness in the EHCD group (Figure 39). In the network graphs, 
Pds5a is only connected to Ociad2 and Slco3a1 in the EHOX network. In contrast, in the EHCD network, 
it is connected to many genes and therefore has a central position. Remarkably, the genes which Pds5a 
is connected to in the two networks are completely different. 
Taken together, two strong networks are present in the early handling group in the PVN, with the two 
networks changing remarkably in response to the adult condition. Interestingly, early life stress seems 
to disrupt these networks. The network in the LMOX group is rather small and no network is formed 
in the group exposed to early life and adult stress (LMCD). 
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Figure 40: Partial correlation co-expression networks in the PVN. 
The specific networks in all experimental groups of the PVN are illustrated. Negative or positive partial correlation is 
depicted in red or green respectivly. The correlation s trength is represented by the edge style. 
Figure 41 depicts the network graphs of the dCA1 region. The situation in this brain region is different. 
Here, the adult condition seems to play the major role with substantial networks present in both 
chronic social defeat stress groups. 
Another large network is present in the LMCD group of the vCA1 (Figure 42). Here, the repeated stress 
condition seems to activate the co-expression of a large number of genes. Interestingly, Pds5a is one 
of the major hub genes with a betweenness value comparable to the EHCD group in the PVN (Figure 
39B). 
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Figure 41: Partial correlation co-expression networks in the dCA1. 
The specific networks in all experimental groups of the dCA1 are illustrated. Negative or 
pos itive partial correlation is depicted in red or green respectivly. The correlation strength is 
represented by the edge style. 
 
Figure 42: Partial correlation co-expression networks in the vCA1. 
The specific networks in all experimental groups of the vCA1 are illustrated. Negative or 
pos itive partial correlation is depicted in red or green respectivly. The correlation strength is 
represented by the edge style. 
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5 Discussion 
In this thesis, the long-term programming effects of early life stress were investigated by two 
approaches in different animal models. In the first part, a candidate approach was applied. We used 
maternal separation to investigate the long-term epigenetic regulation of CRH in the PVN. In the 
second part, a previously in humans established network of GR-response eQTL genes was investigated. 
In a translational approach, the network properties were evaluated following early life stress alone and 
in conjunction with adult stress. 
5.1 Epigenetic programming of CRH expression 
First, long-term programming of gene expression through epigenetic mechanism like DNA methylation 
was investigated. Based on previous results in the lab, which demonstrated epigenetic programming 
of various parts of the HPA axis, the expression and promoter methylation of CRH was analyzed. Initial 
experiments had established sex specific expression differences in adult female mice following 
maternal separation. Therefore, CRH expression and corticosterone levels were investigated across 
the estrous cycle in female mice. In control mice, but not in ELS mice, estrous cycle dependent changes 
in CRH expression and corticosterone levels were detected. The HPA and the hypothalamic–pituitary–
gonadal (HPG) axis are interconnected at various levels. Estradiol activates the HPA axis whereas 
corticosterone suppresses the HPG axis. The sustained CRH and corticosterone levels throughout the 
estrous cycle in maternal separated mice suggest a disturbed synchronization between the HPA and 
HPG axis activity by the adverse early life experiences. As underlying mechanism, we were 
hypothesizing differences in CRH activation due to epigenetic modifications. The proximal CRH 
promoter contains 10 CpG dinucleotides and numerous transcription factor binding sites (Figure 43). 
 
Figure 43: Schematic representation of the CRH Promoter. 
Investigated CpG sites are marked by red lines, colored boxes correspond to experimentally va lidated as well as predicted 
transcription factor binding sites. ERE: estrogen response element; nGRE: negative glucocorticoid response element; AP1: 
activator protein 1; YY1: Yin Yang 1; CRE: cAMP response element; C/EBP half: CCAAT/enhancer-binding protein half site; 
MeCP2: methyl  CpG binding protein 2. 
The best characterized transcription factor binding sites are the negative glucocorticoid response 
element (nGRE) and the cAMP response element (CRE) (King et al. 2002; Nicholson et al. 2004). Also 
estrogen response elements (ERE) are thought to localize at the CRH promoter region (Vamvakopoulos 
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and Chrousos 1993). Furthermore, alternative pathways of estrogen-dependent activation of the CRH 
promoter have been proposed (Miller et al. 2004).  
The CRH promoter is enriched in CpGs, which also overlap with transcription factor binding sites. 
Investigation of CpG methylation of this part seemed especially interesting since DNA methylation is 
known to change the ability of transcription factor binding at its DNA address code. Generally, 
methylated CpGs are known to impair transcription factor binding. On the other hand, CpG 
methylation of regulatory sequences can also increase the binding of specific transcription factors 
(Rishi et al. 2010). However, methylation at the CRH promoter region did not change in maternal 
separated females. This further highlights the stressor-, sex-, and tissue-specific regulation of CRH gene 
expression in accord with several related studies (Raabe and Spengler 2013).  
Within the framework of thesis, the molecular mechanisms of altered CRH expression in female mice 
with a history of maternal separation remained unidentified. Future studies need to address a variety 
of possible mechanisms leading to the observed expression pattern. Beside differences in methylation, 
posttranslational modifications can modulate transcription factor binding as well. Transcriptional 
activation at the CRH promoter is a complex interplay between various proteins . Glucocorticoids 
repress expression through the nGRE whereas the cAMP response element binding protein (CREB)  as 
well as c-Jun–c-Fos heterodimers interact synergistically to activate CRH expression (Nicholson et al. 
2004). CREB is a well-studied transcription factor that is involved in the regulation of neuronal 
plasticity, neuronal growth and survival. Different signaling pathways converge on CREB and regulate 
its activity by phosphorylation (Lonze and Ginty 2002). Therefore, the regulatory processes that could 
be affected by early life stress are manifold. In order to comprehensively investigate these regulatory 
processes, proteomic approaches appear to be necessary. 
Additionally, differences in the innervation of the PVN from other brain regions need to be assessed, 
for example via retrograde tracers. Differences in the cellular composition of the PVN in the response 
to ELS are another possible source of altered CRH expression. Moreover, dendrite outgrowth and 
synaptic morphology of CRH neurons could be investigated. 
5.2 MDD/SCZ-related GR-response eQTL genes in mice 
In a previous study by Arloth et al. (2015), GR-response eQTLs were identified in a cohort of human 
males. The identified eQTL SNPs were then matched with nominally significant hits from large GWAS 
for major depressive disorder as well as schizophrenia. The resulting genes from a tightly connected 
network with some of them associated to both diseases. 
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In a translational approach, we investigated the network properties of these eQTL genes in mice. 
Thereby, exposure to stress could be analyzed in a controlled environment. The interplay between 
early life stress and adult stressors was studied in two mouse models. In the first one, maternal 
separation was combined with acute corticosterone injection before sacrifice. In the second one, 
limited nesting material was combined with chronic social defeat in adulthood. In both animal studies, 
gene expression was measured in stress relevant brain regions. Differential expression analysis on a 
single gene basis did not reveal many significantly regulated genes. A higher number of differentially 
expressed genes was detected in blood, which was only available from the first study. In blood, 
substantial regulation by the acute corticosterone injection was observed. Since the human data was 
also obtained from blood with a similar stimulus (dexamethasone injection) this highlights the 
conserved GR responsiveness between species.  
As the investigated genes were only weakly regulated on a single gene basis and given the network 
connectivity established in humans, the network properties were investigated in the different mouse 
brain regions. Pronounced differences between the two animal models have been found. In the first 
animal model, a strong activation of genes by acute corticosterone treatment was observed. This can 
be deduced from the strong network connectivity in the cerebellum, a brain region unrelated to stress 
regulation. Due to the high abundance of glucocorticoid receptors in the cerebellum (Morimoto et al. 
1996) the pharmacological treatment resulted in strong effects in the corticosterone injected control 
group. Besides that, marked network connectivity was also observed in hippocampal brain regions, 
with the strongest effects in the ventral CA3 across all conditions. This finding is in accord with the 
concept that the hippocampus is a major regulator of the stress response and contains a high number 
of GR. Moreover, peripheral tissues like pituitary and blood showed high network connectivity under 
all conditions.  
In the second animal model, three brain regions stood out in the number of connected nodes and 
edges: the PVN, the ventral and the dorsal CA1. The highest network connectivity was observed in the 
early handling groups of the PVN but also the double stress group of the vCA1 showed high 
connectivity. Especially the PVN but also the CA1 are brain regions well known for their function within 
the stress response and their involvement in stress regulation. This illustrates the validity of the model 
and the involvement of the selected genes in stress related regulatory processes. 
Pds5a could be identified as particularly interesting gene within all networks. It is located centrally in 
two networks, the PVN EHCD group and the vCA1 LMCD group. In these networks, it functions as hub 
gene, influencing the expression of several neighboring genes. This matches well with its potential 
function as cohesin regulatory factor (Zhang et al. 2009). Cohesin works in concert with CTCF to form 
and stabilize chromosomal loops, thereby changing the access to DNA regulatory sequences. As a 
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result, gene regulatory elements either can interact with each other or are insulated from the 
associated genes. However, the details of the underlying regulatory processes are complex, with a vast 
variety of involved factors and the exact role of Pds5a seems difficult to decipher. Pds5a and its 
homologue, Pds5b, have so far been mostly implicated in causing Cornelia de Lange syndrome, a rare 
developmental disorder that is characterized by mental retardation among other deficits. Pds5a 
knockout mice, however, lacked any obvious defects in central nervous system development (Zhang 
et al. 2009).  
The central function of Pds5a is observed in different conditions in the two brain regions. In the PVN, 
the Pds5a hub is activated by chronic social defeat in previously unstressed individuals whereas in the 
vCA1 the activation occurs only after a history of early life stress. This highlights the regional specificity 
and distinct underlying regulatory processes. The ventral hippocampus, especially the CA1 region, has 
been implicated in the tonic regulation of the PVN (Herman et al. 1992). It can be speculated that early 
life stress triggers long-term programming processes in the hippocampus leading to structural changes 
which result in the activation of Pds5 and its co-regulated genes after chronic adult stress. This could 
disturb the regulatory properties of the hippocampus and result in the disruption of the PVN network 
under stressful conditions, which would explain the absence of the PVN LMCD network.  
Overall, the network analysis showed a region specific and stimulus dependent activation of the 
MDD/SCZ-related GR-response eQTL genes. Early life stress, a major risk factor for psychiatric diseases, 
modulates the responsiveness of the co-expression networks. This suggests an involvement of the 
identified genes within stress relevant processes in these psychiatric diseases. Moreover, genes related 
to either MDD or schizophrenia are always intertwined within the network architecture. Therefore, 
the identified genes possibly share regulatory processes that are affected in both diseases.  
To further evaluate the importance of the identified genes in the context of psychiatric disorders, 
several experiments could be conducted in the future. In primary cultures of mouse hippocampal cells, 
regulatory processes could be further evaluated. The use of cultured cells allows the convenient 
addition and depletion of various cofactors. Using cells from knockout animals, regulatory influences 
of specific genes could be analyzed quickly. Further, the use of human induced pluripotent stem cells 
(iPSC) cells could help to translate the insights gained herein back to humans. Human iPSCs could be 
differentiated into neurons and then stimulated with glucocorticoids. The use of the CRISPR/Cas 
system (Clustered Regularly Interspaced Short Palindromic Repeats) would allow further 
manipulations of promoter or enhancer regions. Thereby, the regulatory properties of disrupted 
transcription factor binding sites or structural inhibitions could be detected. In order to evaluate the 
MDD/SCZ-related eQTL genes against the background of the whole transcriptome, microarrays or RNA 
sequencing could be performed. The most interesting brain regions, like the PVN, could thereby be 
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analyzed in more detail. Another technique would be in-situ hybridization, which has the advantage of 
spatial resolution but can only be done for a small number of genes.  
The spatial resolution provided by the micro punching technique is already high. Nevertheless, new 
technical developments include fluorescence-activated cell sorting (FACS) and single-cell RNA 
sequencing. Thereby, even subpopulations of brain regions can be analyzed in detail. Prior to 
sequencing, specific cell populations like neurons or even CRH expressing cells can be isolated via FACS. 
The obtained transcriptomes can further be categorized by gene clustering analysis  and rare cell types 
can be identified. This overcomes the difficulty of cellular heterogeneity, which commonly dilutes 
experimental effects within punching areas. Via single-cell sequencing, cell type specific effects can be 
identified with high sensitivity. This opens the possibility of more detailed investigations and enables 
the identification of the underlying mechanistic properties. 
In conclusion, the set of MDD- and SCZ-related genes identified by GR-response eQTL analysis in 
humans has proven to be relevant in stress related disorders. Two related models of early life stress in 
mice have shown region specific co-expression networks with stress related brain regions being the 
most prominent. So far, most of these genes have not been implicated in psychiatric diseases and their 
functions are largely unknown. Future experiments in animals as well as humans have to strengthen 
the functional involvement of these genes and the related pathways in psychiatric disorders. The 
elucidation of the regulatory processes within and beside the gene networks could establish a more 
thorough understanding of the mechanisms leading to these disorders and pave the development of 
new treatments. 
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8 Appendix 
8.1 Methylation of the CRH gene region 
 
 
Figure 44: CpG density and methylation level around the CRH gene. 
The corticotrophin releasing hormone (Crh) gene is schematically represented at the top (red: untranslated region, green: 
coding region). The percentage of methylation i s depicted according to the genomic position on mouse chromosome 3. 
Data  are derived from NeuN+ cells of 6-week old female mice 
(http://neomorph.salk.edu/brain_methylomes/browser_mm.html). The red square marks the promoter region with the ten 
CpGs  investigated in this study. 
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8.2 GR-response eQTL Genes associated with major depressive disorder or 
schizophrenia 
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8.3 Batch correction blood 
 
Figure 45: Principal component (PC) plots of the batch correction for MS/Co blood samples. 
In the left plot, the samples are colored by RNA extraction batch before surrogate variable analysis; in the right plot, the 
samples are colored by RNA extraction batch after surrogate variable analysis 
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9 List of Abbreviations 
Abbreviation  
5caC 5-carboxylcytosine 
5fC 5-formylcytosine 
5hmC 5-hydroxymethylcytosine 
5hmU 5-hydroxyuracil 
5mC 5-methylcytosine 
ACTH adrenocorticotropic hormone 
ADHD attention deficit hyperactivity disorder 
AMY amygdala 
AN anorexia nervosa 
ANOVA analysis of variance 
AP anterior-posterior 
AP1 activator protein 1 
ASD autism spectrum disorder 
AVP arginine vasopressin 
BER base excision repair  
BNST bed nucleus of the stria terminalis 
BPD bipolar disorder 
C/EBP CCAAT/enhancer-binding protein 
CA cornu ammonis  
CD chronic social defeat stress  
CD Crohn’s disease 
CER cerebellum 
CH3 methyl group 
Co control 
CRE cAMP response element 
CREB cAMP response element binding protein  
CRH corticotrophin releasing hormone 
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats 
CSF cerebrospinal fluid 
DALYs disability-adjusted life years 
dCA1 dorsal hippocampal CA 1 region 
dCA3 dorsal hippocampal CA 3 region 
dDG dorsal dentate gyrus 
ddH2O double-distilled water 
DNA Deoxyribonucleic acid 
DNMT DNA methyl transferase 
DV dorsal-ventral 
EH early handling 
ELS early life stress 
eQTL expression quantitative trait locus 
ERE estrogen response element 
FACS fluorescence-activated cell sorting 
FC fold change 
FDR false discovery rate 
GGMs graphical Gaussians models 
List of Abbreviations 
82 
GR glucocorticoid receptor 
GWAS genome-wide association study 
HPA hypothalamic–pituitary–adrenal 
HPG hypothalamic–pituitary–gonadal  
IBD inflammatory bowel disease 
IP intra peritoneal 
iPSC induced pluripotent stem cells  
IPTG isopropyl β-D-1-thiogalactopyranoside 
LB  lysogeny broth 
LM limited nesting material 
MDD major depressive disorder 
MDS multidimensional scaling  
MeCP2 methyl CpG binding protein 2 
ML medial-lateral 
MR mineralocorticoid receptor 
MS maternal separated 
Nac nucleus accumbens 
NER nucleotide excision repair 
nGRE negative glucocorticoid response element 
OCD obsessive compulsive disorder 
OX ovariectomized female 
PBS phosphate-buffered saline 
PC principal component  
PCA principal component analysis 
PF passing filter 
PFC prefrontal cortex 
PND postnatal day  
POMC proopiomelanocortin 
PVN paraventricular nucleus 
RNA ribonucleic acid 
SCZ schizophrenia 
SEM standard error of mean 
SNP single nucleotide polymorphism 
SOB  Super Optimal Broth 
SSRI selective serotonin reuptake inhibitor 
SV surrogate variable 
SVA surrogate variable analysis 
TB  Terrific Broth 
TDG thymine DNA glycosylase 
TET ten-eleven translocation 
TOP targeted oligo pool 
TS Tourette’s syndrome 
vCA1 ventral hippocampal CA 1 region 
vCA3 ventral hippocampal CA 3 region 
vDG ventral dentate gyrus 
X-Gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
YY1 transcription factor Yin Yang 1 
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